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Abstract 
 The purpose of this study was to examine the influence of psychosocial factors on drug court 
graduation among a medication assisted treatment drug court population. The extant research identifies 
drug courts as effective in reducing recidivism and relapse rates; however meta-analyses of the drug 
court literature reveal that there is little explanation as to why drug courts are effectual and especially 
for whom.  This study examined trauma, mental health, and social support to determine predictive 
psychosocial factors of drug court participants while controlling for certain demographics.  The analyses 
showed that social support was predictive, but failed to identify trauma or mental health correlates.  
Policy implications are discussed. 
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Chapter 1:  Introduction 
 
 Individuals who become involved with the criminal justice system frequently engage in 
substance abusing behaviors.  The relationship between substance use and crime has been well 
established (Andrews & Bonta 2010).  Drug arrests account for the highest number of arrests in the 
United States, with the criminal justice burden for processing these individuals increasing year after year 
despite punitive policies aimed at reducing recidivism (Belenko, Fagin, & Chin, 1991).  Empirical evidence 
also establishes a relationship between mental illness and substance abuse (Frisher, Crome, Macleod, 
Millson, & Croft, 2005; Steadman, Osher, Robbins, Case, & Samuels, 2009).  Additionally, drug offenders 
often report exposure to traumatic stress experiences over the course of their lifetime. These 
experiences can lead to trauma-related disorders or other mental health symptoms (Subica, Claypoole, 
& Wylie, 2012; Wu, Schairer, Dellor, & Grella, 2010). Individuals with mental illness and co-occurring 
mental health and substance abuse disorders are disproportionally arrested and incarcerated at rates 
higher than their counterparts in the justice system without mental health issues (Abram, Teplin, & 
McClelland, 2003; Fazel & Danesh, 2002; Steadman, et al., 2009). A study by the Bureau of Justice 
Statistics using national data found that 76% of jail inmates met criteria for mental illness and substance 
dependence or abuse (James & Glaze, 2006).  More recently, these groups are becoming increasingly 
identified with the criminal justice system, and programs targeting these populations for diversion from 
incarceration to supervised treatment are developing throughout the United States.  Dedicated 
interventions for justice-involved persons with co-occurring disorders or mental illness have 
demonstrated effectiveness.  Examples of these interventions are: pre- and post-booking diversion 
programs, alternatives to sentencing programs such as pre-trial interventions, specialized probation, 
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evidenced-based practices such as forensic intensive case management and assertive community 
treatment, and specialty courts including drug courts and mental health courts.  
 The majority of criminological research on the drug-crime relationship has focused on patterns 
of criminal activity among drug offenders, pathways to substance abuse, influence of delinquent peers, 
racial contexts, desistance strategies, or the increase in incarceration rates in relation to legislative 
efforts of the war on drugs (Baumer, 1994; Durlauf & Nagin, 2011; Krohn, Lizotte, Thornberry, Smith, & 
McDowall; 1996; Mosher, 2001; Schroeder, Giordano, & Cernkovich, 2007; Spohn & Holleran, 2002). 
Although these areas are worthwhile to study, criminological research has overlooked several issues 
related to behavioral health. First, criminological studies of the drug-crime relationship often neglect the 
issues surrounding effective treatment services or criminal justice alternatives for substance abusing 
offenders and overlook possible interaction effects of psychosocial factors among substance abuse 
populations.  Empirical research on substance abuse and crime from a behavioral healthcare perspective 
has identified mental illness and trauma as correlates of substance abuse and criminal justice 
involvement (Carlson, Schafer, & Dufee, 2010; Green, Daroowalla, & Siddique, 2005; Johnson, Ross, 
Taylor, Williams, Carvajal, & Peters, 2006; Messina, Grella, Burdon, & Prendergast, 2008).  Justice- 
involved persons report higher rates of trauma than the general population (Beck, 2000; Hubbard & 
Matthews, 2008; Miller & Najavits, 2012; Sarchiapone, Carlia, Cuomoa, Marchettia & Roy, 2008; CANY-
Women in Prison Project, 2006).  High rates of trauma exposure among substance abusing adults have 
been reported as well (Acierno, 2003; Najavits, 2006; McCauley, et.al, 2009). 
Along with its neglect of mental health and trauma effects on the drug-crime relationship, 
criminal justice research has also overlooked shifting trends from, for instance, the crack cocaine 
epidemic of the 1980s and 1990s to the current prescription drug epidemic (as defined by the Centers 
for Disease Control) that extend beyond traditional drug-crime associations.  Nonmedical prescription 
drug use is quickly surpassing other substances as the most used substance among drug users, second 
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only to marijuana use among individuals aged 12 and older in the United States (NSDUH, SAMHSA, 
2011). Currently, persons aged 18-25 report the highest use of nonmedical prescription drugs and are 
considered the most medicated generation in history (Apahall & Schwartz-Bloom, 2008; Quintero, 
2005). Nevertheless, problems associated with the nonmedical use of prescription medication are 
having far-reaching effects across demographic groups.  Unfortunately, national data on arrest rates for 
nonmedical prescription drug use are not available due to the manner in which drug arrests are 
recorded. However, data from the National Drug Intelligence Center, which surveys law enforcement 
agencies, indicate increases in gang activity related to the distribution of prescription medication, 
increased arrests for possession of narcotics and other psychopharmaceutical drugs without a 
prescription, increased illegal activities in the form of prescription fraud and doctor shopping schemes, 
and associations between pharmaceutical diversion (criminal acts involving prescription drugs) and 
property and violent crime (NDIC, NDTS, 2011).  The consequences associated with the nonmedical use 
of prescription drugs mirror those of other illicit drug use: risks of substance abuse and dependence 
disorders, serious drug-related physical and mental health issues, increased risk factors for involvement 
in criminal activity with subsequent arrests and incarceration, and decreased quality of life issues (family 
disruption, loss of economic and educational opportunities and achievements) (McCabe, Cranford, 
Morales, & Young, 2006). 
A final issue often downplayed in traditional criminological research is the growing shift to 
therapeutic jurisprudence over traditionally adversarial criminal justice responses that have had little 
impact on fighting the war on drugs. Alternatives to incarceration (ATI) programs provide a method to 
merge treatment with supervision.  ATI provides the supervision warranted by the criminal behaviors of 
substance abusing offenders while also providing treatment to improve the issues that led to the crimes 
committed in order to support addiction or that resulted from problems related to addiction.  Drug 
court programs are an example of ATI that have demonstrated positive outcomes.  The drug court 
4 
 
model is an alternative method of criminal supervision that reduces the burden of drug crime on the 
criminal justice system by utilizing mandated treatment in conjunction with close court supervision 
(Hoffman, 1999; NADCIP, 2011, NIJ, 2006) to address drug addiction as the basis for criminal behavior.  
Research findings support drug court effectiveness in terms of decreased rates of recidivism and 
substance abuse relapses (Belenko, 2001; GAO, 2011; Gottfredson & Exum, 2002; Spohn, Piper, Martin 
& Frenzel, 2001).  Additionally, research has demonstrated the benefits of the drug court model in terms 
of cost savings for both judicial processing and law enforcement activities (Huddleston, Marlowe, & 
Casebolt, 2008). However, some researchers have argued that effective outcomes of the drug court 
model are not clearly understood and that what works and how it works, and for whom, need further 
attention (Belenko, 2001; Cisner & Rempel, 2005; Hoffman, 1999; Marlowe, Festinger, Lee, Dugosh, & 
Benasutti, 2006).  
One of the primary issues in drug court evaluation research involves variability in successful 
completion of drug court programs. In order to better discern why drug courts work, an understanding 
of factors associated with successful drug court graduation is necessary in order to make informed 
decisions in the assessment, management, and treatment of justice-involved individuals with substance 
abuse problems.  A shortcoming of the extant literature on drug courts is the scarcity of research 
examining psychosocial characteristics of drug court clients or a focus on treatment outcomes in relation 
to these factors (Bouffard & Richardson, 2007; Hagedorn & Willenbring, 2003).   Furthermore, 
examination of drug court offenders who abuse prescription medication and the study of medication-
assisted treatment programs within the drug court context are fundamental in addressing the serious 
public health and criminal justice burden of the nonmedical use of pharmaceutical drugs.   
A shift in the examination of the drug-crime relationship within criminology is needed to better 
explore an interdisciplinary approach to addressing current issues surrounding substance abuse 
offenders.  To date, criminological research has not consistently or comprehensively evaluated 
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psychosocial factors related to the drug-crime relationship within an interdisciplinary framework, nor 
has there been an emphasis on investigating populations of nonmedical prescription drug users.  Finally, 
although criminologists have examined drug courts and questioned their structure and processes, there 
is a lack of research on for whom drug courts work. A consideration within criminological research of the 
drug-crime relationship as a significant behavioral health care problem with substantial criminal justice 
and public health burdens is important, and further examination of drug court effectiveness in terms of 
the populations it serves contributes to literature on individual level factors that influence program 
completion. 
An examination of psychosocial factors in relation to their contribution to negative or positive 
substance abuse treatment outcomes could be beneficial in terms of identifying risk conditions as well 
as protective factors for successful substance abuse treatment in criminal justice populations.  
Psychosocial factors such as untreated mental health or trauma-related issues could negatively impact 
treatment outcomes (Agerwala & McCance-Katz, 2012; Chan,Huang, Bradley, & Unutzer, 2013), whereas 
psychosocial factors such as access to social support mechanisms could contribute to positive treatment 
outcomes (Dobkin, De Civita, Paraherakis, & Gill, 2002).  The prevalence of co-occurring disorders 
among justice-involved persons and the potential barriers to treatment and recovery these disorders 
present (Warren, Stein, & Grella, 2007) contribute to recidivism and enable the drug-crime relationship.  
An examination of the relationship among psychosocial factors and treatment outcomes contributes to 
the intersection of public safety and public health which could, in turn, influence decision making 
practices within the criminal justice system, and drug courts in particular, to better assess individuals 
who may be eligible for intervention programs and enhance management procedures within programs 
to improve success (Cheesman, Rubio & VanDuisend, 2004).  Since behavioral health disorders account 
for more disability than any other medical problem (Council [SAMHSA], 2004) an emphasis on services 
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and treatment could account for cost savings beyond the criminal justice sector and into the public 
health sector. 
   Although drug courts have established efficacy for reducing recidivism and relapse rates among 
adult substance abuse offenders (Belenko, 1998), the focus on crime reduction outcomes with limited 
focus on mental health outcomes (National Institute on Drug Abuse, 2007) is problematic. Much of the 
program evaluation research on drug court treatment outcomes focused on drug court processes and 
while structural information is relevant, meta-analyses of the literature identified a lack of a clear 
understanding as to how the processes are effective and for whom (GAO, 2005; Mitchell, Wilson, Eggers, 
& MacKenzie, 2012; Shaffer, 2011; Wilson, Mitchell, & MacKenzie,2006); studies have failed to provide 
an explanation as to why drug courts work for some populations and not others (Marlowe, et. al, 2006).  
The literature demonstrates positive program characteristics (Huddleston & Marlowe, 2011) and 
demographic characteristics that contribute to program completion (Bhati & Roman, 2010; Bouffard & 
Richardson, 2007), but results are often mixed (Merrall & Bird, 2009; see Appendix A) and gaps in the 
literature remain (Stinchcomb, 2010).  The question has been do drug courts work and the answer is yes, 
but the questions as to why and for whom remain ambiguous.  Information on the psychosocial 
characteristics of drug court participants could offer further explanation for the efficacy of drug court 
treatment. Drug courts are designed to treat non-violent offenders who have committed drug offenses, 
and while they do not explicitly address mental illness or co-occurring disorders as part of the key 
components of drug court, it is not unlikely that drug court clients demonstrate mental health or 
trauma-related symptoms given their prevalence rates among substance abusers.  It would be both 
appropriate and beneficial to develop informed assessment procedures within drug courts to assist with 
the identification of current mental health symptoms and to direct effective trauma-informed care as 
unmet mental health care needs are one of the most relevant issues for relapse.  Identifying co-
occurring, trauma-related disorders or current mental health symptoms, and providing relevant 
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treatment, could better address the factors related to offending behaviors, which in turn could 
contribute to better treatment outcomes as well as provide a better understanding as to why drug court 
treatment works and for whom.  Likewise, studying drug court populations that better represent current 
trends in substance use patterns, i.e., offenders who abuse prescription medication, could contribute to 
research that examines criminogenic risks (i.e., matching intensity of service to risk level) (Andrews 
Bonta, 2010; Andrews & Dowden, 1999; Marlowe, et al., 2006). 
 The following study attempted to explore participant demographics and psychosocial factors 
within a drug court context.  Specifically, an examination of psychosocial factors as predictors of drug 
court graduation was undertaken to determine the possibility of a negative relationship between 
traumatic stress, mental health symptom severity, and program success.  Also examined was the 
possibility of a positive relationship between access to prosocial support systems and successful 
program completion in terms of drug court graduation.  The objective was to provide a better 
understanding of how psychosocial factors influence successful or unsuccessful drug court graduation.  
The hypotheses guiding this study were that exposure to traumatic stress and resulting mental health 
symptoms would negatively impact successful drug court graduation and that access to prosocial 
support systems would positively impact successful drug court graduation.  In addition, this study 
investigated these issues within a sample of prescription drug abusers assigned to medication-assisted 
drug court treatment, a little studied population in criminological research.  The results of this study 
were intended to provide information regarding the relationship between psychosocial factors and drug 
court graduation that may provide useful data to better understand for whom drug court works and to 
possibly reveal important policy implications for addressing the needs of individuals with co-occurring 
disorders within a criminal justice context.  Finally, this study contributes to the literature by shifting the 
focus from traditional drug-crime research to examining current trends using an interdisciplinary 
perspective.  
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Chapter 2:  The Criminal Justice and Public Health Burdens of Substance Abuse 
Substance abuse, in the forms of both the use of illegal drugs and the misuse of prescription 
medication, is a pervasive problem in the United States, resulting in a multiplicity of issues for not only 
the individual drug user, but also for family members, the community, and society as a whole.  The 
social impact of substance abuse has led to a multitude of policies, programs, and sanctions in an effort 
to “fight the war on drugs”. These strategies have focused on predominately punitive measures in an 
effort to deter illegal drug activities (manufacture, use/misuse, and distribution) (King, 2008).  Drug 
violations accounted for the largest increase in arrests between the 1980s to present day (Mauer & King, 
2007a).  In 2005, the largest proportions of arrests were for possession and distribution of illegal drugs, 
with four out of five arrests being made for possession of illegal substances and one out of five arrests 
being made for distribution of illegal substances (Belenko, 1998; Mauer & King, 2007b).  According to 
the FBI’s Uniform Crime Reporting (UCR) Program, law enforcement made an estimated 12,408,899 
arrests nationwide in 2011; the highest number of arrests, 1,531,251 (8.1%), was for drug-related crimes 
(UCR, 2011).  Of the 1,531,251 arrests in 2011 for drug-related crimes, 1,252,563 (81.8%) were for 
possession of a controlled substance.  
 Substance abuse tied to criminal justice involvement is not limited to illegal drugs; even with 
federal and state level government regulations, the misuse and abuse of prescription medication is a 
growing problem in the United States. Abuse of prescription medications including opiates, 
benzodiazepines, stimulants, and other tranquilizers and sedatives is becoming more commonplace 
(Becker, Fiellin, & Desai, 2007; Johnston, O’Malley, Bachman, & Schulenberg, 2006). Results of the 
National Survey on Drug Use and Health (NSDUH, 2010-2011) found that 1 in 22 (4.5%) Americans age 
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12 and older had taken a prescription medication for nonmedical purposes at least once in the year 
prior to being surveyed (SAMHSA, 2011).  The National Center on Addiction and Substance Abuse 
(Califano, 2005) found that prescription drug abuse rates exceeded rates of cocaine use, heroin use, use 
of hallucinogens, and use of inhalants combined.  The harmful consequences of prescription drug abuse 
have resulted in an increase in both fatal and non-fatal overdoses (Cai, Crane, & Poneleit, 2010).  The 
Drug Abuse Warning Network has estimated that approximately 25% of emergency room treatment 
admissions for drug abuse are attributable to prescription drugs (Gibbs & Haddox 2003).  The costs 
associated with the nonmedical use of prescription opiates was estimated at $53.4 billion in 2006, with 
criminal justice costs accounting for $8.2 billion (Hansen, Oster Edelsberg, Woody, & Sullivan, 2011).  
The Coalition Against Insurance Fraud (2007) estimated the cost of the abuse of prescription pain 
relievers at $72.5 billion.  The Centers for Disease Control and Prevention has classified prescription drug 
abuse as an epidemic, and several State and Federal policies have been implemented to address the 
issue (prescription drug monitoring programs, Medicaid programs aimed at reducing doctor/pharmacy 
shopping, training for law enforcement) (Paulozzi, Weisler, & Patkar, 2011).  Many individuals who 
abuse illicit drugs and/or misuse or abuse prescription medications are self-medicating untreated 
psychological issues (Khantzian & Treece, 1985) or use drugs as a coping mechanism for dysphoria 
(Mueser, Drake, & Wallach, 1998); these issues culminate in individuals engaging in criminal activities to 
support their addiction.  The legitimate uses of prescription drugs (i.e., pain management and substance 
abuse treatment) affect criminal justice policies and create difficulties in combating misuses and abuse 
(Schadelbauer & Katz [DEA}, 2001); however, arrest rates continue to climb for both illicit drug use and 
prescription drug crimes (FBI: “Crime in the United States 2011”, 2012).   
 According to the Department of Justice Bureau of Justice Statistics (2007), the prison 
population in the United States as of 2007 was 2,413,112.  Research showed that more than 80% of 
individuals incarcerated in state prison systems exhibited evidence of serious involvement with drugs 
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and/or alcohol (Belenko & Peugh, 2005).  Studies indicated that an estimated 95% of individuals 
released from state prison systems with histories of drug abuse resume their drug use upon release 
(Martin, Butzin, Saum, & Inicardi, 1999) and a large majority will be rearrested, reconvicted, and/or re-
incarcerated (Langan & Levin, 2002).  Justice-involved individuals with mental illness and substance 
abuse represent a large majority of the incarcerated population, with 76% of jail inmates accounting for 
the highest rate followed by state prisoners (74%) and federal prisoners (64%) (James & Glaze, 2006).   
 To understand the impact of the drug-crime relationship, a consideration of factors other than 
strictly drug violations in the criminal context is also important. According to Bureau of Justice Statistics 
(2009) findings, 28% of individuals incarcerated at the federal level and 32% incarcerated at the state 
level disclosed being under the influence of illicit drugs while committing their crime.  Engagement in 
criminal behavior could be considered as a means to support drug addiction.  Furthermore, drug use 
could influence motivations of individuals who commit crime (see for example, Goldstein, 1985). The 
Substance Abuse and Mental Health Services Administration (SAMHSA) sponsors an annual measure of 
drug use in the United States; the National Survey on Drug Use and Health (NSDUH) provides national 
and state-level data on the use of tobacco, alcohol, illicit drugs (including non-medical use of 
prescription drugs), and mental health (SAMHSA, NSDUH, 2011).  According to the NSDUH, in 2011, an 
estimated 22.5 million Americans aged 12 or older were current (past month) illicit drug users (SAMHSA, 
NSDUH, 2011).  Table 1 presents results of the 2011 NSDUH according to type of substance. 
Table 1. Excerpts from the National Survey on Drug Use and Health 2011 
Current users in past month aged 12 or older Number of persons Percentage of 
population 
Marijuana 18,100,000 7.0% 
Non-medical use of psychotherapeutic drugs 6,100,000 2.4% 
Non-medical use of pain relievers  4,500,000 1.7% 
Cocaine 1,400,000  0.5% 
Hallucinogens 972,000 0.4% 
Non-medical use of stimulants 970,000 0.4% 
Methamphetamine 439,000 0.2% 
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Heroin 281,000 0.1% 
Source: NSDUH, SAMHSA, 2011 
 Substance abuse is a complex social problem, and the best approaches to dealing with justice- 
involved substance abusing individuals have been argued for decades (Walker, 2006; Wilson & 
Petersilia, 2002; Garland, 2001; Trebach & Inciardi, 1993). For many years, incarceration was considered 
the most appropriate method, the focus being deterrence and punishment over rehabilitation (Wexler, 
1994). Legislation was enacted for more severe sentences for drug offenders, attributable to societal 
complaints about the lack of appropriate criminal justice responses to drug crimes (Wexler, 1994). 
Certain research findings indicated that “nothing works” in terms of rehabilitation, which supported 
demands for harsher punishments (Martinson, 1974; Warner & Kramer, 2009).  Punishment strategies 
have long been the primary means of drug crime prevention.  However, the economic impact of these 
“war on drugs” strategies is extensive, including increased costs to the judicial and criminal justice 
systems, a loss of productivity in these sectors, enormous healthcare costs, and personal damages to 
individuals and families in terms of housing issues (Caulkins & Sevigny, 2005; Mauer, 2003), barriers to 
education (Mauer, 2003; Correctional Association, 2007), loss of income and healthcare benefits (NIDA, 
1992), problems associated with entitlement benefits (Allard,2002), loss of parental rights, and loss of 
voting rights (Sentencing Project, 2009) due to drug related arrests and incarcerations, and a drain to 
social services including child safety investigations and foster care placements among other issues 
(ONDCP, 2009).  
 The economic impact associated with drug control policies, particularly within the criminal 
justice system, (i.e., law enforcement, judicial components, and corrections) coupled with the costs for 
society (i.e., health care expenditures, productivity losses, and victimization costs), is enormous. In fact, 
the National Drug Control Budget summary for fiscal year 2013 requested twenty billion dollars for 
support in the areas of drug abuse prevention ($1.4 billion), treatment ($9.2 billion), and domestic law 
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enforcement ($9.4 billion) (National Drug Control Strategy: FY 2013 Budget and Performance Summary).  
According to the National Drug Intelligence Center (NDIC -U.S. Department of Justice), the economic 
impact of illicit drug use in the United States in 2007 was $193,096,930.  The NDIC (2011) estimates both 
direct and indirect costs of substance abuse in three areas: crime costs, health costs, and productivity 
costs.  Each of the three principal areas are divided into many components – some of the results of the 
2011 report by NDIC on the economic impact of substance use are presented in Table 2(NDIC, 2011). 
Table 2. Economic Impact of Illicit Drug Use on American Society 
Crime Economic Impact 
Criminal Justice System Costs $56,373,254 
Crime Victim Costs $1,455,555 
Other Crime Costs $3,547,885 
Total Crime Costs $61,376,694 
Productivity Economic Impact 
Labor Participation Costs $49,237,777 
Specialty Treatment Costs - State Level $2,828,207 
Specialty Treatment Costs - Federal Level $44,830 
Hospitalization Costs $287,260 
Incarceration Costs $48,121,949 
Premature Mortality Costs Non-homicide $16,005,008 
Premature Mortality Costs Homicide $3,778,973 
Total Productivity Costs $120,304,004 
Total Health Costs $3,723,338 
Source: NDIC, 2011 
 The problem of prescription drug abuse has an even greater burden.  After a period of stability 
of rates of treatment admission for substance use from 1999-2009 for most substances, rates of 
treatment admission for opiate use increased by 430% over the same time period (SAMHSA, 2011).    
According to the Drug Abuse Warning Network in 2011, there were over one million emergency 
department (ED) visits for nonmedical use of prescription drugs (1, 244,872), which accounted for nearly 
one quarter of all ED visits (26.4%) and half (50.5%) of all drug-related visits.  From 2004 to 2011, 
emergency room department visits related to the abuse or misuse of prescription drugs in the United 
States increased for all pharmaceuticals by 132%; oxycodone (Oxycontin) related visits increased by 
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263%, hydrocodone (Vicodin, Norco) related visits increased by 107%, hydromorphone (Dialudid) 
related visits increased by 438%; and amphetamine-dextroamphetamine (Adderall) related visits 
increased by 650% (Drug Abuse Warning Network, 2011).Conversely, a less than 1% increase was seen 
for visits related to the use of methamphetamine, heroin, cocaine, and marijuana (Office of National 
Drug Control Policy, 2010). According to the Centers for Disease Control and Prevention (2010), the 
number of deaths due to unintentional overdose of opioid analgesics (prescription painkillers such as 
Oxycontin and Percocet), were almost twice the number caused by cocaine and five times the number 
caused by heroin in 2007; increases in the number of unintentional overdose deaths per year involving 
opioid pain relievers increased nearly four times from 2,900 deaths in 1999 to 11,500 deaths in 2011 
(CDC, 2011).  
 Despite punitive legislation and severe drug policies, drug crimes continue to increase along 
with economic costs and social welfare burdens.  An acknowledgment that the problems associated with 
substance abuse could not be reconciled through punitive measures has resulted in the consideration of 
alternative policies and practices to deal with drug offenders (Belenko, 2000).  Some recent criminal 
justice practices have revealed an emphasis on treatment over incarceration, and research has 
supported a “what works” approach that has proven economic benefits (King & Pasquella, 2009).  
Substance abuse treatment is one of the major efforts to reduce the societal costs associated with 
substance abuse, particularly criminal justice costs (Harwood, Hubbard, Collins, & Rachal, 1988).  
Substance abuse treatment, in both prison-based programs and community services, has evidenced 
reductions in both substance use and recidivism among offender populations (Zanis, Mulvaney, Coviello, 
Alterman, Savitz,& Thompson, 2003).  There is a need for criminological research to incorporate a 
behavioral health perspective that focuses on therapeutic justice and psychosocial factors to address the 
problem of substance abuse. An interdisciplinary approach that emphasizes behavioral health may be 
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even more important given current trends toward the nonmedical use of prescription drugs and the 
subsequent criminal justice and public health burdens on society. 
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Chapter 3:   Substance Abuse and the Criminal Justice System:  A Behavioral Health Perspective 
 The connection between substance abuse and crime is well established in the research 
literature (Incardi, McBride & McCoy, 1997; MacCoun, Kilmer, & Reuter, 2003; MacKenzie & Uchida, 
1994; Tonry & Wilson, 1990).  Higher rates of substance abuse exist among justice-involved individuals 
(arrestees, probationers, parolees, and those currently incarcerated) than among individuals who are 
not justice- involved (ONDCP, 2009).  Findings from the Arrestee Drug Abuse Monitoring program 
revealed that 64% of male arrestees tested positive for at least one of five illicit drugs: (a) cocaine, (b) 
opioids, (c) marijuana, (d) methamphetamines, and (e) phencyclidine (U.S. Department of Justice, 2000). 
Criminal behaviors committed by individuals with substance use disorders can range in severity from 
non-violent crimes such as possession or trespassing to more severe criminal acts such as prostitution, 
driving under the influence, domestic violence, robbery, assault, and homicide (Bennett, Holloway, & 
Farrington, 2008).  The manufacture and distribution of illegal drugs and the misuse of legal drugs 
(prescription medication) are also violations of the law that can lead to arrest and incarceration 
(MacCoun, Kilmer, & Reuter, 2003; White & Gorman, 2000). 
Substance abuse is considered a main criminogenic variable within the risk, need, responsivity 
model of criminal behaviors and is predictive of recidivism (Dowden & Brown, 2002). Drug related 
crimes coupled with tough on crime stances and policies related to the “war on drugs” have led to 
increased incarceration rates in jails and prisons across the United States which, in turn, has introduced 
a large number of offenders with substance use disorders, mental illness, and co-occurring disorders 
into the criminal justice system (Breslau, Davis, & Schultz, 2003; Finn & Newlyn, 1997).  Treatment 
options for offenders with these problems are limited, and without access to appropriate behavioral 
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health protocols, this justice-involved population is likely to continue to cycle through the criminal 
justice system (Center for Health Improvement, 2009). 
 With rising criminal justice costs and incarceration rates, federal and state criminal justice, 
mental health care, and substance abuse agencies are examining more effective ways, including utilizing 
system collaboration, to treat drug addiction among justice-involved populations in order to increase 
the possibilities of moderating the drug-crime cycle.  Pharmacotherapy or medication-assisted 
treatment (MAT) is one treatment option with proven cost effectiveness and positive therapeutic 
outcomes; however, MAT has been slow to be adopted within the criminal justice system (AMA, 2008).  
MAT utilizes medication, such as methadone and buprenorphine in conjunction with counseling and 
behavioral health services to combat addiction (SAMHSA, 2004).  Many opponents to MAT consider it to 
be substituting one substance for another when in actuality it is a safe and effective means to reduce 
cravings and limit withdrawal symptoms, while regulating changes in brain chemistry for individuals on 
maintenance programs (Nester & Malenka, 2004).  Jails and prison officials are also reluctant to have 
“drugs” in their institutions (ONDCP, 1999).  However, research findings demonstrate MAT as the most 
cost effective treatment modality for opioid addiction (CSAT, 2005).  Offenders who received MAT while 
incarcerated demonstrated positive outcomes while detained (total time served) and post-release 
(decreases in recidivism rates) (Maremmani, Pacini, & Lovrecic, 2004).  For offenders under community 
supervision, research indicated that utilizing drug court treatment that includes medication as part of 
the community-based treatment service reduces the risks of recidivism (continued criminal behaviors) 
and relapse (reengagement of illicit and/or nonmedical use of prescription medication) (NIH, 1999; 
Tomasino, Swanson, Nolan, and Shulman, 2001).   Consideration of evidence-based medication-assisted 
treatment by the criminal justice system as an effective component of rehabilitation is essential to 
diminishing the drug-crime relationship. 
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Therapeutic Jurisprudence: Drug Courts 
The estimated societal costs of substance abuse was estimated at $190 billion annually and has 
extensive repercussions for society as a whole beyond  those experienced by the individual abusing 
drugs (Office of National Drug Control Policy [ONDCP,2011).  The criminal justice system bears the 
greatest expense of substance abuse due to the costs surrounding adjudication and correctional services 
(Butzin, Saum, & Scarpitti, 2002; Marlowe, 2010). In an effort to reduce costs associated with processing 
and incarcerating individuals with not only substance abuse issues, but also mental health or co-
occurring disorders and to break the cycle of incarceration due to behaviors associated with these 
issues, several resourceful judicial solutions have been implemented throughout the United States. A 
focus on a non-adversarial approach that considers the well-being of the offender and the issues that 
led to their criminal disposition is the foundation of the legal philosophy known as therapeutic 
jurisprudence (Wexler, 2001).  Incorporating therapeutic approaches in criminal justice procedures 
allows the legal process to attend to individual difficulties that, in turn, impact larger social problems. 
Therapeutic jurisprudence encompasses such legal components as legislation, criminal justice 
procedures such as diversion programs (both pre and post-booking), and judicial procedures such as 
pre-trial interventions.    
Therapeutic jurisprudence provides the foundation for drug courts, a judicial means to divert 
non-violent offenders from traditional criminal justice practices of incarceration or standard probation 
into treatment programs, thereby receiving treatment for substance abuse or co-occurring mental 
health disorders that very likely contributed to their criminal justice involvement. Drug courts were 
developed as instruments of change to address extra-legal factors that influence criminal behavior and 
contribute to a revolving door of justice where specific groups of offenders regularly cycle in and out of 
the justice system (Belenko & Dumanovsky, 1993).  The initial formation of drug courts, although 
experimental, was an innovative attempt to combat the greatly increasing correctional population while 
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focusing on the offenders’ underlying issues that contribute to greater social problems. Drug courts 
offer alternatives to incarceration that impact public safety and improve public health (National Institute 
of Justice, 2006).  The first drug court (DC) was implemented in Miami-Dade County, Florida in 1989; 
currently, there are over 2,600 drug courts operating throughout the United States (National Institute of 
Justice, 2012). Many of these specialty courts focus on specific populations of drug offenders such as 
juveniles and veterans or have specific expectations such as family reunification (GAO, 1995; Goldkamp, 
White, & Robinson, 2001; Schaffer, 2011; Wilson, Mitchell, & MacKenzie, 2006).   
The drug court model operates under a fundamentally different set of standards than typical 
criminal justice procedures; the prosecutor, defense attorney, judge, and other criminal justice 
professionals (for example, probation officers) work together using a non-adversarial approach in an 
effort to break the drug-crime cycle by providing an opportunity for the offender to receive treatment 
and begin steps towards a prosocial lifestyle (Marlowe, 2003; National Drug Court Institute, 2000; OJP, 
2006; Senjo & Leip, 2001).  Drug court operations vary according to jurisdiction; however, the drug court 
model follows a general principle in that it offers court-supervised substance abuse treatment for non-
violent offenders to remain in the community instead of being incarcerated in jail or prison.  This 
approach centers on two benefits. First, it provides a public health-focused intervention strategy for the 
drug-crime relationship that incorporates close criminal supervision with substance abuse treatment as 
a means to attend to addiction as the cause of criminal behaviors in an effort to reduce recidivism. 
Second, the drug court approach reduces the burden of the criminal justice system (Hoffman, 1999; 
Marlowe, et. al., 2006; NADCP, 2011; NIJ, 2006).  Post-adjudication drug courts usually require a guilty 
plea on the part of the defendant, with the understanding that successful completion of the program 
will result in a suspended sentence, reduced charges, or a dismissal of charges and that failure to comply 
will result in prosecution (Brown, Allison, Nieto, 2011;King & Pasquarella, 2009).  Some drug courts 
operate under a deferred prosecution model where defendants are not required to plead guilty; under 
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this type of drug court, jail or prison diversion is offered for first time offenders with the same outcome 
of prosecution for non-compliance (King & Pasquarella, 2009; Turner et al., 2002).  Both post-
adjudication and deferred prosecution drug court models usually allow successful graduates to follow 
procedures to have their records expunged (Nolan, 2002).   
 Drug courts provide community-supervised substance abuse treatment as an alternative to 
incarceration for specified treatment lengths depending on jurisdiction; treatment duration ranges from 
six to eighteen months, with the majority of drug court clients participating in drug court for one year 
(National Center for State Courts, 2011)  The drug court team typically involves the judge, district 
attorney, defense counsel, drug court coordinator, substance abuse treatment provider, and sometimes 
a probation officer or other law enforcement official, and/or a social services representative.  The judge 
is the principal member of the drug court team and provides not only sanctions for non-compliance, but 
also rewards and encouragement for compliance (Harvard Law Review, 1998; NADCP, 1997).  Drug court 
clients (usually labeled as such to avoid terms like “offender” since this is a non-adversarial treatment-
based approach) are required to participate in court mandated substance abuse treatment, submit to 
regular drug screens, and attend regularly scheduled drug court appearances to discuss progress 
(NADCP, 1997).  Additional requirements for drug court clients vary by jurisdiction, but can include 
required parenting classes, completion of GED or vocational programs, community service, paying child 
support, or obtaining employment, among other things (National Drug Court Resource Center, 2012).  
Key components of drug courts according to the National Bureau of Justice Assistance in collaboration 
with the National Association of Drug Court Professionals are presented in Table 3.  
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Table 3. Ten Key Components of Drug Court 
Component 
1. Drug court integrates alcohol and other drug treatment services with justice system case 
processing. 
2. Using a non-adversarial approach, prosecution and defense counsel promote public safety while 
protecting participants’ due process rights. 
3. Eligible participants are identified early and promptly placed in drug court. 
4. Drug court provides access to a continuum of alcohol, drug and other related treatment and 
rehabilitative services. 
5. Abstinence is monitored by frequent alcohol and other drug testing. 
6. A coordinated strategy governs drug court responses to participant’s compliance. 
7. Ongoing judicial interaction with each drug court participant is essential. 
8. Monitoring and evaluation measure the achievement of drug court goals and gauge effectiveness. 
9. Continuing interdisciplinary education promotes effective drug court planning, implementation, 
and operations. 
10. Forging partnerships among drug court, public agencies, and community-based organizations 
generates local support and enhances drug court effectiveness. 
Source: OJP, 2004 
Drug offenders who participated in specialty courts have been found to be more likely to abstain 
from substance use and to be less likely to be re-arrested than drug offenders in standard probation 
(Banks & Gottfredson, 2003, 2004; Deschenes, Ireland, & Kleinpeter,2009; Gottfredson, Najaka, & 
Kearly, 2003; Gottfredson, Kearly, Najaka, & Rocha, 2007; Roman, Townsend, & Bhati, 2003; Shaffer, 
2011; Wilson, et al., 2006). Although much of the research supports the notion that treatment is more 
likely than traditional forms of adjudication that do not involve treatment to reduce future criminal 
behaviors among justice-involved substance abusers (Dynia & Sung, 2000; Goldkamp, White, & 
Robinson, 2001; Spohn & Piper, 2004; Taxman & Bouffard, 2005; Wilson, Mitchell, & MacKenzie, 2006), 
questions remain as to what types of treatment work best for which types of offenders (Arabia, Fox, 
Caughie, & Marlowe, 2008; Festinger, Marlowe, Lee, Kirby, Bovasso & McLellan, 2001;Marlowe, 
DeMatteo, & Festinger, 2004; Taxman & Bouffard, 2005). 
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 Criticism in regard to the research on drug courts identifies two problem areas:  insufficient 
evaluation of drug court procedures and outcomes and methodological issues with drug court studies 
(Belenko, 2001; Cissner & Rempel, 2005; Finn, 2006; Goldkamp, White, & Robinson, 2001; Shaffer et al., 
2010; Turner et al., 2002).  For example, in a review of adult drug court research by the Government 
Accountability Office (GAO) in 2005, only 27 of 117 (23.8%) evaluations of drug court programs were 
considered to be based on sound methodology (GAO, 2005).  The lack of methodologically sound 
evaluations leaves many remaining questions as to why drug courts work (NDCI, 2006). 
 In a report that summarized findings from federally funded drug courts, the GAO (2011), 
established that recidivism rates were lower among drug court participants than among comparison 
groups.  However, there is no standard definition of recidivism within the drug court outcome literature: 
some studies define recidivism as new arrests (Belenko, 2001, Gottfredson & Exum, 2002; Roman, 
Townsend, & Bahti, 2003; Spohn, et al, 2001), some define recidivism as new convictions (Spohn, et al., 
2001), and other studies define recidivism as new court appearances (Miethe, Lu, & Reese, 2000).  
Furthermore, the time at which recidivism is measured also varies: some studies measure recidivism 
during drug court (Belenko, 2011; Gottfredson & Exum, 2002); others measure post-drug court 
graduation recidivism rates (Miethe, et al, 2000; Spohn, et al., 2001), and some studies measure time to 
recidivism (Spohn, et al, 2001). 
Studies on relapse rates of drug court participants encounter the same lack of a standardized 
definition of relapse, timeframes of relapse, and how relapse is reported (self-report vs. official data, 
i.e., urinalysis).  In a continuation study of previous research, Gottfredson et al. (2005) utilized self-
report data as a measure of relapse and found that drug court participants reported less drug use in the 
past year than individuals assigned to standard adjudication.  The GAO (2011) also indicated that drug 
court participants were less likely to use drugs than those persons in comparison groups; 56% of drug 
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court graduates reported drug use as compared to 76% of non-drug court offenders; this report 
measured both self-reported drug use and urinalysis results. 
 Overall, outcome studies of drug court completion indicated that certain demographic and 
criminogenic features affect drug court graduation rates, with drug court graduation correlates including 
gender, race, age, marital status, level of education, employment status, criminal history, drug of choice, 
and various drug court characteristics or operations, such as length of time the drug court has been in 
operation and sanctions applied to the participant.  However, much of the literature demonstrates 
mixed results or contradictory findings (see Appendix A).  For example, many studies find no differences 
between men and women drug court participants in terms of graduation rates  (Evans, Li, & Hser, 2009; 
Hepburn & Harvey, 2007; Marlowe et al, 2003; Seachrest & Shicor, 2001; Senjo & Leip, 2001).  In 
contrast, Belenko’s (2001) review of drug court programs found that some studies indicated that men 
were more likely to complete drug court treatment, but that women were more likely to demonstrate 
positive outcomes during treatment.  One explanation for this gender difference is that women 
experience more gender-specific issues than men that may interfere with their capability of meeting 
drug court program requirements, such as having primary caregiver duties that prevent them from 
attending required meetings (Neal, 2010).  Bouffard and Richardson (2007) noted that although 
outcome studies provide evidence that drug courts work, the research reveals contradictory results in 
terms of personal characteristics of drug court participants that fail to account for specific issues that 
impact drug court completion. Their review of the literature indicates that while some research notes 
certain characteristics such as age to be a predictive factor for completion, other research indicated that 
the same characteristic results in higher dropout rates (Bouffard & Richardson, 2007).  
 Outcome study findings in regard to age also present contradictory findings, with some research 
indicating no difference in drug court graduation according to the age of participants (DeMatteo, 
Marlowe, Festinger, & Arabia, 2009; Gallagher, 2013; Shaffer et al., 2010) and others demonstrating a 
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relationship between age and drug court completion (Cissner & Rempel, 2005; Hickert, Boyle & 
Tollefson, 2009; Young and Belenko, 2002).  Still other studies show that age does predict drug court 
completion, but that directionality matters. For example, in terms of the effect of age on drug court 
graduation, Hepburn and Harvey’s (2007) study found that older drug court participants were more 
likely to graduate than younger participants; this finding is supported by other research (Hartley & 
Phillips, 2001, Hickert, Boyle & Tollefson, 2009).  Conversely, Senjo and Leip’s (2001) study found that 
younger participants were more likely to complete drug court treatment.  These studies demonstrated 
age as a predictive factor of completion, but failed to account for why age is a factor given that age 
effects varied across studies. 
 Studies that examined race as a correlate of drug court completion also found mixed results, 
with a number of studies indicating that white/Caucasian drug court participants were more likely to 
complete drug court than participants of other races (Belenko, 2001; Hepburn & Harvey, 2007; Schiff & 
Terry, 1997; Senjo & Leip, 2001). Other studies found no difference among races in relation to drug 
court graduation rates (Evans et al., 2009; Peters, Haas & Murrin, 1999).  One explanation for this 
contradiction is that although race can be a factor in drug court completion, other factors can interact 
with race to influence outcomes (Rempel & DeStefano, 2001; Schaeffer, et. al, 2010). 
 Studies that examined education had similar contradictory outcomes.  Some studies found that 
level of education was positively related to drug court completion (DeMatteo et al., 2009; Hepburn & 
Harvey, 2007; Hickert, Boyle, & Tollefson, 2009; Schaeffer et al., 2010; Mullany & Peat, 2008; Schiff & 
Terry, 1997), while others found no effect (Senjo & Leip, 2001; Hiller, Knight, & Simpson, 1999).  In a 
study by Hickert, Boyle, and Tollefson (2009), the likelihood of successful drug court graduation 
increased by 15% for each increase in grade level for education attainment.  Other studies have found 
that high school graduates were more likely to successfully complete drug courts when compared to 
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participants who did not graduate high school or earn their GED (Gray & Saum, 2005; Mullaney & Peat, 
2008). 
 In response to questions regarding contradictory findings of drug court evaluation research, 
some authors note that interaction effects among program variables or individual level characteristics 
limit the ability to predict program outcomes and that all findings should be considered cautiously, as 
results from one drug court evaluation may not be generalizable to all drug courts (Belenko, 2001; 
Marlow et al., 2004).  Despite challenges in assessing the factors that contribute to effective drug 
courts, there is empirical support that the drug court model reduces recidivism (Banks, & Gottfredson, 
2004; Peters & Murrin, 2000; Listwan, Shaffer, Hartman, 2009) and demonstrates positive treatment 
effects (Lowenkamp, Holsinger, & Latessa, 2005; Wilson, Mitchell, & Mackenzie, 2006).  Furthermore, 
more than one million participants have successfully completed drug court treatment programs (Nolan, 
2008).  Although there are legitimate methodological issues with drug court outcome studies, there is 
evidence indicating that drug courts effectively reduce recidivism and relapse regardless of definition or 
timeframe (Sanford & Arrigo, 2005; Roman, Townsend, & Bahti, 2003). However, research findings on 
recidivism rates or relapse measures offer little explanation of the characteristics of the participants in 
these programs to provide a more comprehensive understanding of who successfully completed drug 
court treatment and why. A determination of whether there are predictable differences between drug 
court participants who successfully completed mandated treatment and those who do not would better 
answer questions about how and why drug courts work.  A focus on individual level correlates such as 
mental health, traumatic experiences, and social support could contribute to a more distinctive 
determination of predictors of drug court completion.  
Mental Health Symptoms, Substance Abuse, and Drug Courts 
 The extant literature on drugs and crime indicates that substance abuse, mental health 
symptoms, and criminal behaviors both independently and in conjunction with one another expend a 
25 
 
severe social cost for Americans (Levinthal, 2008; Nocon, Berge, Astals, Martin-Santos, & Torrens (2007).   
The Substance Abuse and Mental Health Services Administration (SAMHSA, 2010) estimates that up to 
10 million adults experience co-occurring mental health and substance use disorders in any given year; 
the term co-occurring disorder (COD) refers to co-occurring substance use (e.g., abuse or dependence) 
and mental health disorder (DSM-IV-TR, 2000).  Co-occurring disorders are diagnosed independently, 
and clinicians rule out the possibility of multiple symptoms resulting from a single disorder (CSAT, 2006).  
  Research has demonstrated that individuals with mental illness are at greater risk for 
developing a substance use disorder (Drake et al., 2001; Gil-Rivas, Grella, & Prause, 2009).  Clinical 
studies found that up to 75% of clients had lifetime co-occurring disorders (CSAT, 2007). Individuals 
suffering from mental illness experience higher arrest rates than individuals without mental illness and 
are disproportionately represented in incarcerated populations (Baillargeon, Penn, Knight, Harzke, 
Baillargeon & Becker, 2009; Lamb & Weinberger2005; Steadman & Naples, 2005; National GAINS 
Center, 2001).  Many reasons exist for this overrepresentation; however, for most justice-involved 
individuals with mental illness, the main reason for incarceration is a lack of access to mental health 
services or other appropriate resources (Cobb, 2006; Draine & Herman 2007, Drapkin, 2003; NTAC, 
2002).  Steadman et al. (2001) reported that prevalence rates of serious mental illness among jail 
inmates was estimated at over 7%; this is 2 to 3 times higher than prevalence rates of serious mental 
illness found in the general population.  Legislative policies such as mandatory sentencing and three 
strikes laws have also, unintentionally, contributed to higher rates of incarceration of mentally ill or co-
occurring offenders (Hartwell, 2004).  Research findings for co-occurring disorders among incarcerated 
populations mirror those of clinical studies, indicating that 75% of inmates have co-occurring disorders 
(National GAINS Center, 2001).  A report by the Department of Justice (DOJ, 2006) stated that many 
justice-involved persons with mental illness have treatable disorders such as major depression, bipolar 
disorder, and substance use disorders.  However, correctional institutions are ill-equipped to properly 
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address the mental illness and substance use treatment needs of inmates. Although the majority of 
federal (94%) and state (82%) institutions provided some type of substance abuse treatment (SAMHSA, 
2002), many justice-involved individuals go without mental health treatment altogether or without 
proper integrated treatment for co-occurring disorders that accurately address their issues (DOJ, 2006; 
Roskes & Feldman, 1999). Unfortunately, jails and prisons have become the main provider of mental 
health and substance abuse services despite limited capabilities and resources to address the needs of 
the mentally ill (SAMHSA, 2002 & APA, 2008).  Regrettably, due to deinstitutionalization, there are more 
persons with serious and persistent mental illness who are incarcerated in jails or prisons than in state 
hospitals (Daniel, 2007).  
 Findings from the National Survey on Drug Use and Health (SAMHSA, 2011) indicate that among 
the 18.9 million adults in America with substance use disorder in the past year, 42.3% had a co-occurring 
mental illness; among those adults without a substance use disorder, 17.6% had a mental illness.  In 
2011, adults with a mental illness in the past year (25.2%) were more likely to use illicit drugs than adults 
who did not have a mental illness in the past year (11.2%) (SAMHSA, 2011). This pattern was similar 
across various types of substance use, including the use of marijuana, cocaine, heroin, hallucinogens, 
and the nonmedical use of prescription medications. Substance use among adults with mental illness in 
the past year was highest among those with serious mental illness (31.3%), moderate mental illness 
(27.3%), and mild mental illness (21.7%), as compared to substance use among adults without mental 
illness in the past year (11.8%) (SAMHSA, 2011).  Mental illness (which typically goes undiagnosed until 
well into adulthood) most often precedes substance use disorders (Kessler, 2004; Kessler, Berglund et 
al., 2005); substance abuse may be a means to cope with untreated mental illness or as a mechanism to 
deal with painful life experiences that may be attributed to an underlying mental illness (i.e., 
stigmatization, social isolation, poverty, and homelessness) (Henwood & Padgett, 2007; Laudet, Magura, 
Vogel, & Knight, 2004).  The National Survey on Drug Use and Health (NSDUH) found that 10.8 million 
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adults (4.6%) reported an unmet need for mental health care in the past year; 45.4% of these individuals 
(4.9 million adults) did not receive any type of mental health services in the past year (SAMHSA, 2011).  
The consequences of untreated mental illness and co-occurring disorders may result in a decrease in 
quality of life, problematic interpersonal relationships, job loss, exposure to trauma and violence, 
homelessness, and criminal justice involvement (SAMHSA, 2011). 
 Gil-Rivas, Grella and Prause’s (2009) study of individuals with co-occurring disorders found that 
a significant number of adults entering substance abuse treatment met criteria for co-occurring 
disorder; individuals with co-occurring disorder had higher rates of recent hospital admissions 
(psychiatric and medical) and reported more severe psychosocial functioning problems compared to 
individuals without co-occurring disorders (substance use only) (Gil-Rivas et al., 2009).  Gil-Rivas et al. 
(2009) also established that a large majority of participants experienced trauma and that 35% met 
criteria for PTSD.  Results of this study indicated that traumatic experiences and symptoms of 
depression and anxiety were associated with an increase in substance use after residential treatment. 
 Research has also found a relationship between mental health symptoms and nonmedical 
prescription drug use (NMPDU) (Becker, Fiellin, & Desai, 2007; Becker, Sullivan, Tetrault, Desai, & 
Fiellen, 2008; O’Brien, 2005; Sullivan, Edlund, Steffick, & Unutzer, 2005), particularly associations 
between NMPDU and depression (Conway, Compton, Stinson, & Grant, 2006), NMPDU and suicidality 
(Vidourek, King, & Knopf, 2010), and NMPDU and panic disorder, anxiety disorders, and phobias (Huang, 
et al., 2006).  Individuals suffering from posttraumatic stress disorders are at an increased risk for 
nonmedical prescription drug dependence (Chilcoat & Breslau, 1998a, 1998b; Tetrault, Desai, Becker, 
Fiellin, Concato, & Sullivan, 2008). The motivations for nonmedical use of prescription drugs are 
comparable to the motivations for other illicit drug use, particularly the self-medication hypothesis (Ford 
& Schroeder, 2009, McCabe, Boyd, & Teter, 2009; Wu, Pilowsky, & Patkar, 2008).  In fact, those 
individuals who choose prescription drugs over other illicit drugs in order to self-medicate report doing 
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so because of the perceived safety (medicine), dose-response predictability (desirable and undesirable 
effects are known based on dosage), and the pharmacological specificity (known therapeutic effect for 
specific symptoms) (Cicero, Inciardi, & Munoz, 2005; Quintero, 2009; Quintero, Peterson, & Young, 
2006; Volkow & Swanson, 2003).  However, the use of prescription medications without the supervision 
of a medical professional is dangerous, and individuals who misuse or abuse prescription medication are 
at an increased risk for accidental overdose, dangerous interactions with other illicit drugs, poisoning 
that can lead to death, suicidal thoughts or actions, adverse withdrawal symptoms, and tolerance that 
can lead to increased use and dependence (Hearn, Rose, Wagner,Ciarleglio, & Mash, 1991; Hernandez & 
Nelson, 2010; SAMHSA, 2004).  Understanding psychosocial factors such as mental health correlates of 
NMPDU is important for targeting criminal justice screens for substance abusing offenders who may 
benefit from specialized treatment modalities that target specific needs.  
 Research on the effects of mental health correlates on drug court graduation is limited, but also 
demonstrates mixed findings.  Some studies found no relationship between mental health and drug 
court outcomes (Dematteo, Marlowe, Festinger, & Arabia, 2009; Cosden, et al, 2006).  Other studies did 
find associations between mental health factors and drug court outcomes (Cissner& Rempel , 2005; 
Evans, Li, & Hser, 2009;Garrity, et al, 2007; Gray & Saum, 2005; Hickert, et al, 2009;  Mendoza, Trinidad, 
Nochajaski, & Farrell, 2013).  Gray and Saum (2005) examined the relationship between mental health, 
gender, and drug court completion and found that gender (women), race (white), and education (higher 
levels) were positively correlated with drug court graduation, but that depression, being prescribed a 
medication for mental health problems, and drug use severity were negatively correlated with drug 
court graduation. The authors suggest that assessing for mental health symptoms at the time of 
treatment admission would allow for coordinated services aimed at improving clients’ mental health 
that could subsequently impact treatment progress and increase the likelihood of successful drug court 
graduation.  The findings of Cissner and Rempel’s 2005 study indicate that drug court participants with 
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co-occurring disorder are less likely to complete drug court than those participants without a mental 
health diagnosis.  Additionally, studies have shown that mental health issues are associated with 
program incompletion or failure.  Evans, Li, & Hser (2009), found that psychiatric conditions measured 
with the Addiction Severity Index were more prevalent among non-completers than by those individuals 
who completed drug court. Hickert, Boyle, and Tollefson (2007) found that drug court participants who 
experienced symptoms of depression were more likely to drop out of treatment than those without 
symptoms. Finally, Hiller, Knight, and Simpson (1999) found that symptoms of depression, anxiety, and 
hostility were positively associated with program dropout. 
 Many studies examine the relationship between mental health and substance abuse (Jacobsen, 
Southwick, & Kosten, 2001; Hein, Zimberg, Weisman, First, & Ackerman, 1997; Subica, Clypoole, & 
Wylie, 2012; Triffleman, 2003; Triffleman, Marmar, & Ronfeldt, 1995), substance abuse treatment 
outcomes in relation to mental health (Ford, Hawke, Alessi, Ledgerwood, & Petry, 2007; Hein, Nunes, 
Levin, & Fraser, 2000; Ouimette, Finney, & Moos, 1999; Ouimette, Brown, & Najavits, 1998; Petersen, & 
Zettle, 2009; Schaffer & Najavits, 2007), and treatment models for substance abuse and mental health 
(Addictions and Trauma Recovery Integration (ATRIUM) [Miller & Guidry, 2001]; cognitive behavioral 
therapy [Mueser & Fox, 2002; Brady et al., 2001; Donovan et al., 2001]; Seeking Safety [Najavits, 2002, 
2007]; Substance-Dependence-Posttraumatic Stress Disorder Therapy [Triffelman, 2000]; Trauma 
Recovery Empowerment Model [Fallot & Harris, 2002]; The Triad Women’s Project [Clark & Fearday, 
2003] ). However, the research on mental health and drug court outcomes is sparse (Hagedorn & 
Willenbring, 2003; Garrity, Prewitt, Joosen, Tindall, Webster, & Leukefeld, 2008).  More research is 
needed to examine the relationship between mental health symptoms and drug court outcomes.  A 
better understanding of individual characteristics that could impact successful drug court completion 
could lead to more effective assessment and treatment interventions targeting specific needs of drug 
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offenders and/or specific populations experiencing co-occurring disorders (i.e, veterans or domestic 
violence or sexual assault survivors).   
Trauma, Substance Abuse, and Drug Courts  
Similar to the effects of mental health disorders, traumatic stress experiences may produce 
considerable and persistent effects on functioning that can lead to maladaptive coping mechanisms such 
as substance abuse or dependence.  Individuals who experience traumatic stress events in their lifetime 
may develop trauma-related symptoms that can result in diagnoses of trauma-related disorders such as 
posttraumatic stress disorder (PTSD) and Acute Stress Disorder (ASD) (Breslau, Davis, & Schultz, 2003; 
Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Khoury, Tang, Bradley, Cubells,& Ressler, 2010).  
Long term effects of trauma may also manifest in symptoms of anxiety and depression (Ford, Courtois, 
van der Hart, Nijenhuis, & Steele, 2005; Johnson, Cohen, Brown, Smailes, & Bernstein, 1999).  
Additionally, traumatic stress experiences may result in a variety of other internalizing and externalizing 
behaviors, particularly substance abuse (Breslau, Davis, Peterson, & Schultz, 2000; Stewart, Pihl, Conrod, 
& Dongier, 1998; Sacks, McKendrick, & Banks, 2008). Recent studies related to substance abuse 
treatment advised that a lack of trauma assessment and subsequent trauma-informed care when 
appropriate may result in less comprehensive treatment, consequently decreasing rates of prolonged 
abstinence after substance abuse treatment completion (Covington, 1999; Hodges, 2003; Najavits, 2003, 
2007). 
 Many symptoms of substance abuse can be associated with the long-term effects of trauma, 
such as nightmares, mood swings, irritability, and experiencing extreme highs and lows (Covington, 
1999); other common symptoms among substance use disorders and trauma are depression, anxiety, 
and substance abuse (Brier, 1992).  Common mental health problems among individuals in substance 
abuse treatment that may affect treatment outcomes are: anxiety, depression, eating disorders, 
posttraumatic stress disorder, trauma histories, and suicide attempts (Broner et al., 2002; Haywood et 
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al., 1995; Henderson, 1998; Owen, 1999; Peters & Hills, 1999; Teplin, Abram, & McClelland, 1996). 
Individuals who have experienced trauma at any time in their lives are more likely to develop mental 
health issues and substance use disorders, and many go without treatment for these issues, which may 
affect their overall functioning (Alexander, 1996; Goodman, Rosenberg, Mueser, & Drake, 1997; CSAT, 
2009).  Individuals with histories of traumatic stress experiences have a higher likelihood of substance 
abuse. Their use of drugs and alcohol can be a method of self-medicating to alleviate symptoms 
associated with trauma and mental illness (Covington, 1999; Najavits, 2004) or as a means to cope with 
negative feelings associated with or disturbing memories of their trauma (Coffey, Stasiewicz, Hughes, & 
Brimo, 2006; Najavits, 2007).  Trauma is not always addressed in substance abuse treatment, since the 
focus is on relapse prevention (Hightower, Smith, & Hightower, 2006; Walsh et al., 2007). However, 
given the strong association between trauma and substance abuse (Brady, Back, & Coffey, 2004; 
Chilcoat & Breslau, 1998; Chilcoat & Menard, 2003; Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; 
Hien, Cohen, & Campbell, 2005; Karadag, Sar, Tamar-Gurol, Evren, Karagoz, & Erkirian, 2005; Read, 
Brown, & Kahler, 2004), a key component to successful treatment outcomes may require addressing the 
trauma.   
 National prevalence rates for experiences of potentially traumatic events in adults over their 
lifetime range from 65-80% (Roberts, Gilman, Breslau, Breslau, & Koenen, 2011).  Men are more likely 
than women to experience combat or accident related trauma and women are more likely to experience 
victimization or the loss of loved ones (Pietrzak, Goldstein, Southwick, & Grant, 2011). Women and men 
with traumatic stress experiences are more likely to abuse substances (Kilpatrick, Acierno, Resnick, 
Saunders, & Best, 1997) and are more likely to exhibit symptoms that may affect treatment outcomes 
such as depression and anxiety (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995).  
 Research on the association between trauma and the nonmedical use of prescription 
medication is scarce, with relatively few studies examining this area. However, the limited findings do 
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indicate a link between opioid use and psychological distress (Jamison, Butler, Budman, Edwards & 
Wasan, 2010; Sung, Richter, Vaughan, Johnson, & Thom, 2008).  Manchikianti and colleagues (2007) 
examined psychological factors in opioid and illicit drug use in chronic pain patients and found increased 
drug abuse among those patients with higher rates of depression, anxiety, and somatization; the 
researchers noted gender differences, with more women exhibiting signs of depression and subsequent 
drug abuse and more men exhibiting signs of somatization and subsequent drug abuse.  The extant 
literature also provides evidence of a relationship between women’s experiences of sexual assault and 
NMPDU (McCauley, Amstadter, Danielson, Ruggiero, Kilpatrick, & Resnick, 2009) and increased risk of 
NMPDU among adolescents with traumatic event histories (McCauley, et al., 2010).   
 Although information on the relationship between substance abuse (illicit drug use and NMPDU) 
and trauma is available, information on the prevalence of trauma among drug court participants is scant 
and information on drug court outcomes in regard to trauma exposure is non-existent.  In a study of 
lifetime trauma exposure and posttraumatic stress disorder in women sentenced to drug court by 
Sartor, et al., (2012), the authors found that only 29 out of 319 (9%) women did not endorse any 
traumatic events; 71% had trauma exposure without PTSD and 20% met criteria for PTSD.  Although 
female drug court participants were at a high risk for experiencing traumatic stress, correlations 
between trauma exposure and other study variables were not accounted for and drug court outcomes 
in relation to the study variables were not examined (Sartor, et al., 2012). 
 It is highly likely that a significant number of drug court participants have experienced trauma, 
and this could impact drug court graduation rates.  There is a need for research on the effects of trauma 
on drug court graduation, as the extant literature is severely limited on this topic. The associations 
among trauma, substance abuse, and related mental health symptoms are relevant to both the criminal 
justice entities and treatment providers in that this relationship could negatively impact both criminal 
recidivism and relapse rates. Research supports that PTSD mediates the adverse effects of trauma 
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exposure among individuals with co-occurring disorders (Subica, Claypoole, & Wylie, 2012) and that the 
combination of trauma history and trauma symptoms even without meeting criteria for a PTSD diagnosis 
can influence addiction relapse (Tate, Brown, Unrod, & Ramo, 2004).  Furthermore, research suggests 
that integrated care that combines treatment for trauma-related symptoms and substance abuse can 
not only decrease the likelihood of relapse, but also alleviate symptoms of suffering that contribute to 
substance abuse (Brown, 2000, Cohen & Hien, 2006; Sacks et al, 2008).  Incorporating trauma 
assessment in drug court programs in conjunction with trauma-informed care when necessary could 
provide answers to some of the whys and hows of effective drug court outcomes.  Identifying traumatic 
stress experiences as a correlate of substance abuse and determining if trauma predicts drug court 
outcomes could facilitate a better understanding of both individual level characteristics that influence 
drug court graduation and better explain the interaction effects found in the outcome literature. 
Social Support, Substance Abuse, and Drug Courts 
 Although mental health problems and trauma may adversely affect drug court outcomes, 
individuals with strong social supports may evidence more positive outcomes. Research on social 
support has demonstrated the important role that positive social networks, access to personal support 
systems, and perceptions of social support have in relation to both successful substance abuse 
treatment and improvements in psychosocial functioning and motivation for recovery (Chao et al., 2013; 
Chong & Lopez, 2005; Davis & Jason, 2005;  Dobkin, De Civita, Paraherakis, & Gill, 2002; Ellis, Bernichon, 
Yu, Roberts, & Harrell, 2004;  Gainey, Peterson, Wells, Hawkins, & Catalano, 1995).  House’s (1981) 
sociological research on stress and social supports classified social support behaviors into four areas 
including emotional support (love, caring, and empathy), instrumental support (tangible needs), 
informational support (advice and information), and appraisal support (information for self-evaluation). 
These different types of support can be provided to or for individuals through a variety of social or 
interpersonal relationships, such as friends, family members, colleagues at work or school 
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environments, or by community service providers.  The functional aspect of social support can be 
further divided into two domains: enacted or perceived support (Calysn, 2004).  Enacted support 
represents actual support received by an individual, whereas perceived support is the individual’s 
perception of the availability of support, irrespective whether the person receives or accesses the 
support (Calysn, 2004). 
 Research findings from studies on substance abuse treatment program outcomes demonstrate 
that social support consistently predicts effective substance abuse treatment (Zerger, 2002) and 
contributes to prolonged abstinence from substance abuse (Havassey, Wassserman, & Hall, 1995).  
Dobkin, De Civita, Paraherakis, and Gill (2002) found higher dropout rates among individuals in 
outpatient substance abuse treatment who reported low levels of social support. Additional research 
has shown that substance abuse treatment clients who have positive social relationships are more likely 
to successfully complete treatment (Watkins, Shaner, & Sullivan, 1999).  Laudet, Cleland, Magura, Vogel, 
and Knight (2004) report that social support for individuals in recovery is most important during the 
beginning stages of treatment, because individuals may be struggling with abstinence and motivation 
for change.  A study by Warren, Stein, and Grella (2007) also supported this finding; results indicated 
that the availability of social support when clients entered treatment predicted improvement in 
substance abuse and mental health outcomes.  
  Additional research findings indicate that individuals with substance use disorders and low 
social support had an increased risk for onset of mental illness, demonstrating a relationship between 
social support and mental health symptoms (Pevalin & Goldberg, 2003).  In a study of substance abuse 
and co-occurring disorders among the homeless, Lam and Rosenheck (1999) found that perceived social 
support was positively associated with substance abuse treatment and improved mental health 
outcomes.   
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 There is a dearth of information on the role of social support and treatment outcomes for 
individuals who misuse or abuse prescription medication; however, the few studies available on MAT for 
opioid users offer conflicting findings.  Smith and Rosen’s study (2009) of barriers to social support for 
older methadone maintenance clients found that past traumatic experiences influenced a lack of trust 
and self-isolation among clients which the authors concluded could affect abstinence during and after 
treatment.  Kidorf and colleagues (2005) studied a behavioral intervention within a hospital-based 
medication-assisted treatment program where participants were encouraged to include non-drug using 
family or friends in their treatment session.  The authors found increased rates of abstinence among 
those clients with access to social support.  Finally, Wasserman, Stewart, and Delucchi (2001) found that 
both structural and functional social support increased abstinence among opioid maintenance patients.  
 Social connectedness of drug court participants is less accounted for in the research, but the few 
studies that have examined social interactions (isolation vs. connectedness) found conflicting results.  
Rempel and DeStefano (2001) found that social isolation of drug court participants in terms of living 
alone or in socially isolated neighborhoods was not significantly related to program outcomes, but that 
predictors of general social connectedness, such as employment, being enrolled in school, or having a 
stable living environment, were positively related to drug court completion.  On the other hand, Hickert, 
Boyle, and Tollefson (2009) found that living alone or in socially isolated neighborhoods had negative 
impacts on drug court graduation and that drug court participants who spent more time with family 
were more likely to graduate from drug court treatment than participants who did not spend time with 
family.  Correspondingly, Hiller, Knight, and Simpson (1999) found that although drug court participants 
were socially connected, their deviant peer networks predicted failure to graduate from drug court. 
Investigation of the association between social support and treatment outcomes for NMPDU clients is 
necessary, given the complex relationship between mental health symptoms and substance abuse and 
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evidence that suggests isolation and loneliness caused by these symptoms could negatively impact 
successful treatment outcomes. 
 Research on the association among trauma, mental health problems, substance abuse, and 
social support demonstrates similar findings in regard to lower levels of social support being associated 
with negative outcomes and higher levels of social support being related to positive outcomes for both 
psychosocial functioning and treatment recovery (Ashley, Marsden, & Brady, 2003; El-bassel, et al., 
1996).  Individuals who have experienced trauma and perceive themselves as having less access to 
positive social support are more likely to engage in negative coping mechanisms such as substance 
abuse and are more likely to develop mental health symptoms in relation to their trauma experiences 
(Cook, et al., 2005; Knight, Logan, & Simpson, 2001).   Furthermore, women with trauma and substance 
abuse histories are more likely to experience negative social and criminal justice outcomes than men in 
these situations; women with trauma and substance abuse are more likely to live in poverty, be single 
parents, be at risk for losing custody of their children, and be more likely to engage in criminal activities 
such as prostitution (Cohen & Hein, 2006; Ehrmin, 2001; Najavits, et al., 1997).   These findings 
emphasize the importance of assessing psychosocial factors such as trauma, mental health symptoms, 
and access to prosocial supports in order to tailor treatment needs to provide the most benefit for the 
client as well as society.  By examining these psychosocial influences within a drug court context, further 
information can be gained on factors that influence drug court graduation.  
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Chapter 4:  Research Design and Methods 
 There is an established research literature on positive findings of alternatives to sentencing 
programs (Anglin, Douglas, Longshore, & Turner, 1999; Clear & Schrantz, 2011; Miller, 2004), particularly 
drug court outcomes (Gallagher, 2013; Mitchell, Wilson, Eggers, MacKenzie, 2012; Rempel, Green, & 
Kralstein, 2012).  However, gaps remain in our knowledge of certain factors that influence drug court 
program success or the lack thereof.  In particular, although it is established that involvement in drug 
court programs increases the likelihood of positive outcomes for justice-involved substance abusers, 
research demonstrates that these outcomes are not universal and that for some, drug court programs 
do not work.  Questions remain regarding for whom drug courts work.  Given the significant social 
impact and vast criminal justice burden related to substance abusing offenders, a more comprehensive 
determination of participant characteristics that affect successful drug court completion should be 
considered.  Research demonstrates a significant relationship between negative psychosocial factors 
such as trauma, mental illness, and substance use (Asberg & Renk, 2012; Belenko, 2006; Kingston & 
Raghavan, 2009; Lesperance, Moore, Barret, Young, Clark and Ochshorn, 2011; Picken & Tarrier, 2011; 
Rosenberg, 2011; Stover, MacMahon, & Easton, 2012).  Additionally, the literature demonstrates a 
relationship between positive psychosocial factors and recovery, such as prosocial support systems 
(Havassy, Hall & Wasserman, 1991; Maguire, 2001; Norris, 2009; Spjeldnes, Jung, Maguire, & Yamatani, 
2012).  The literature on co-occurring disorders and trauma-informed care emphasizes the need for 
simultaneous treatment for both mental health or trauma-related symptoms and substance use in order 
to decrease the likelihood of substance abuse relapses and criminal justice recidivism while providing a 
therapeutic response to the effects of mental illness and/or trauma (Abbott, 2003; Amaro, Chernof, 
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Brown, Arevalo, & Gatz, 2007; Dass-Brailsford & Myrick, 2010; Minkoff, 2008; Najavits, Weiss, & Shaw, 
1999; Najavits, 2004).  This exploratory study utilizes secondary data to examine the demographic and 
psychosocial factors associated with drug court graduation among a medication-assisted treatment 
population.  Using a variety of measures to assess trauma experiences, mental health symptom severity, 
and prosocial support in relation to drug court graduation affords a more comprehensive approach to 
understanding the impact of drug court while accounting for psychosocial factors that may influence 
substance abuse treatment.  Furthermore, research on medication-assisted treatment populations is 
limited and more information is needed.   Studying demographic and psychosocial factors facilitates a 
further exploration of the question, for whom are drug courts beneficial? The results of this study 
contribute to the literature on psychosocial factors and their impact on drug court outcomes.   
Procedures 
 The data for this study come from a pre-existing de-identified data set from an evaluation of a 
medication-assisted drug court treatment program.  The Hillsborough County Medication-assisted Drug 
Court Treatment Program (MADCT) and the external evaluation component were funded through a 
federal grant by the Substance Abuse and Mental Health Services Administration – Center for Substance 
Abuse Treatment (SAMHSA-CSAT).  The purpose of the MADCT program was to offer offenders with 
opiate addiction a harm-reduction based outpatient treatment option as an alternative to abstinence-
based programs or jail/prison – with the ultimate goal of supporting clients in their efforts to achieve 
sobriety and stability.  Successful treatment completion and compliance with drug court requirements 
allow first-time drug offenders the opportunity to avoid having a felony conviction upon completion of 
the program.  Secondary data were utilized to assess the effects of psychosocial factors (traumatic stress 
experiences, mental health symptom severity, and social support) on drug court graduation.  It was 
hypothesized that individuals with higher instances of traumatic stress experiences and more severe 
mental health symptoms would have less favorable drug court outcomes in terms of successful 
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graduation, whereas individuals with access to prosocial support systems would have more favorable 
drug court outcomes in terms of successful graduation.  
 Data were collected from individuals who were enrolled in a medication-assisted drug court and 
attending court-ordered substance abuse treatment.  Prior to data collection, approval from the 
University of South Florida Institutional Review Board (IRB) was obtained, and all study personnel 
completed instruction in human subjects research.  Each participant gave informed consent to 
participate in the evaluation study from which data for this study were used.  A modification to the IRB 
was approved to allow for further analyses using these data to inform this dissertation. 
Sample 
The sample for this study was composed of participants in the Hillsborough County Medication-
assisted Drug Court Treatment (MADCT) Program of the 13th Judicial Circuit, Hillsborough County, 
Florida.  All participants in this program had histories of drug abuse and were opiate users.  Drug abuse 
is characterized by a maladaptive pattern of substance use to the point where the individual experiences 
significant cognitive and behavioral impairment or emotional distress that has an impact on work, 
school, or the home (APA, 2000; DSM-IV).  Eligibility criteria for the MADCT program included male and 
female offenders who had: (1) prescription drug-related charges, (2) no history of violent criminal 
offenses, (3) no diagnosis of severe mental illness, (4) no alleged sexual perpetration, and (5) willingness 
to participate in medication-assisted drug court treatment. Program participation was voluntary.  The 
MADCT program provided approximately six months of outpatient treatment to individuals who abused 
or misused prescription opiates.  The treatment utilized an evidence-based treatment protocol, the 
Matrix model, in conjunction with medication-assistance.  The Matrix Model utilizes cognitive-
behavioral concepts to reinforce positive behavioral changes (Rawson, et. al, 1995 & 2002). MADCT 
treatment emphasized individual contact with a substance abuse counselor, education about drug 
abuse, relapse prevention, social support, twelve-step participation, and issues critical to addiction and 
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relapse.  Participants received medication management in the form of methadone or suboxone as part 
of their substance abuse treatment and were required to attend the clinic daily in order to obtain their 
medication. All MADCT clients participated in individual and group counseling sessions, weekly 
attendance at a self-help group meeting, such as Alcoholics Anonymous/Narcotics 
Anonymous/Methadone Anonymous, one to two random drug screens per week, and monthly judicial 
reviews.  Although most participants completed the treatment component of drug court within six 
months, the majority remained in drug court for judicial reviews and drug testing up to one year or until 
they satisfied all of the requirements of the drug court program. Upon successful graduation from the 
MADCT program, participants’ charges were dropped and they were allowed to petition the court to 
have their records expunged.  Individuals who did not satisfy the requirements of the MADCT program 
were sentenced for their original charges and served jail time.  Some participants did not successfully 
graduate due to absconding from treatment (these had active warrants or were jailed), were 
incarcerated for charges not related to the charge that led them into the MADCT program, were 
transferred to a different jurisdiction for criminal justice reasons, or were involuntarily discharged from 
treatment due to non-compliance.  
The sample for the current study was drawn from the population of all individuals who were 
participants in the MADCT program between January, 2010 and April, 2012. To have their data included 
in the analysis, participants must have completed all study measures and must have been discharged 
from the program and their graduation or non-graduation status recorded. Only 108 of the original 145 
participants had completed all study measures.  Of these 108 who had completed all study measures, 90 
had been discharged from the program and were thus eligible for inclusion in the analysis. To ensure the 
representativeness of the sample, analyses were performed to examine potential demographic 
differences among the entire drug court population (N= 145), the included sample (n=90), and the 
excluded sample (n=55, those still active in the drug court program and/or declined to complete all 
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study measures). No statistically significant differences emerged among any of these groups (see Table 
4). In the absence of any significant differences, analyses were restricted to the final sample that were 
no longer active in drug court and had completed all study measures (N=90). 
Table 4. Comparison of Total Population, Excluded, and Final Sample Demographics 
 
 Total 
Population 
(N = 145) 
Excluded 
 Sample 
(N = 55) 
Final 
 Sample 
(N = 90) 
 
 
Significance 
Mean 
or N 
SD or 
% 
Mean 
or N 
SD or 
% 
Mean 
or N 
SD or 
% 
C
o
va
ri
at
e
s 
Age 28.15 7.89 28.4 8.36 28.0 7.64 t(143) = -0.338, p = .736 
Gender 
   Female 
   Male 
 
79 
66 
 
54.5% 
45.5% 
 
35 
20 
 
63.6% 
36.4% 
 
44 
46 
 
48.9% 
51.1% 
 
 
X2(1) = 1.088, p = .297 
Education 
    LT High 
School 
    High School 
    GT High 
School 
 
43 
43 
59 
 
29.7% 
29.7% 
40.7% 
 
21 
18 
16 
 
38.2% 
32.7% 
29.1% 
 
22 
25 
43 
 
24.4% 
27.8% 
47.8% 
 
 
 
X2(2) = 5.384, p = .068 
Employment 
    Unemployed 
    Employed 
 
94 
50 
 
64.8% 
34.5% 
 
38 
16 
 
70.4% 
29.6% 
 
56 
34 
 
62.2% 
37.8% 
 
 
X2(1) = 0.989, p = .320 
 
In the final sample used for the present study, there were 44 women (48.9%) and 46 men 
(51.1%).  Participants ranged in age from 18-59 (X = 28.15, SD = 7.89).  As depicted in Table 4, 22 
participants reported their level of education as less than high school (24.4%), 25 reported earning a 
high school diploma or equivalent GED (27.8%), and 43 participants reported completing some college 
or more (47.8%).   The majority of participants were unemployed at baseline (62.2%). 
Research Questions 
In order to address the impact of psychosocial factors on drug court graduation, four questions were 
examined: 
 What are the demographic correlates of drug court graduation? 
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 What is the relationship between individuals’ experiences of traumatic stress and drug court 
graduation?  
 What is the relationship between mental health symptom severity and drug court graduation? 
 What is the relationship between prosocial support systems and drug court graduation?  
Results of the study inform a discussion of whether demographic and psychosocial factors should be 
considered in alternatives to sentencing programs for justice-involved individuals with substance abuse.   
Measures of Variables 
Demographics – For the purposes of this study, demographics include the following variables: 
age (in years), gender (female = 1, male = 0), level of education (measured as less than high school =1, 
high school or GED equivalent = 2, or some college or college graduate = 3), and employment (measured 
as employed = 1 or unemployed = 2).  These variables were chosen as covariates because extant 
empirical research has identified these as being predictors of drug court outcomes. 
Drug Court Graduation - Participants’ drug court graduation status was coded as yes (successful 
graduation = 1; N = 68) or no (did not graduate = 0; N = 22); this information was provided by the court.  
MADCT participants are recorded as “graduates” when they complete treatment and satisfy all drug 
court requirements including regular judicial reviews and drug testing beyond treatment completion. 
MADCT participants are recorded as “non-graduates” when they fail to meet drug court requirements 
(completing treatment, attending judicial reviews, no further criminal justice involvement). 
Traumatic Stress - Traumatic stress experiences were measured using the Traumatic Stress Scale 
(TSS), part of the Global Appraisal of Individual Needs (GAIN) instrument (Dennis, White, Titus, & 
Unsicker, 2006). The Traumatic Stress Scale encompasses a range of exposure(s) to trauma over the 
lifetime as either a victim or a witness to victimization.  The TSS is a 13-item measure of past year 
symptoms or memories related to past trauma (e.g., post-traumatic stress disorder PTSD), current 
trauma (e.g., acute stress disorder (ASD) or other disorders of extreme stress (DES or complex PTSD; e.g. 
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related to on-going childhood maltreatment, battering victims, domestic violence or sexual abuse 
survivors) associated with exposure to traumatic events. Some examples of items on the TSS are: When 
something reminds you of the past, you become very distressed and upset; you had nightmares about 
things in your past that really happened; you felt guilty about things that happened because you felt like 
you could have done something to prevent them? Scores are the sum of ‘‘yes’’ responses, with higher 
scores indicating more problems related to memories of traumatic events. Scores range from 0-13 and 
the authors provide guidelines for interpretation based on prior research determining demographic 
norms (Modisette, Hunter, Ives, Funk, & Dennis, 2009): scores are interpreted as no (0 symptoms 
endorsed), moderate (1–4 symptoms endorsed), and high (5–13 symptoms endorsed). The TSS is based 
on the Civilian Mississippi Scale for PTSD (Hyer, Davis, et al., 1991; Keane, Caddell, & Taylor, 1988; King, 
King, et al., 1993; Kulka, Schlenger, et al., 1991; Lauterbach, Vrana, et al., 1997; Vreven, Gudanowski, et 
al., 1995).  For the present study, the Cronbach’s alpha coefficient of reliability is α= .934.   
Mental Health Symptom Severity – Mental health symptom severity was measured using the 
Global Severity Index (GSI), which is based on the Brief Symptom Inventory (BSI; Derogatis, 1982). The 
BSI is a 53-item measure that assesses common psychological symptoms.  The Brief Symptom Inventory 
is an abbreviated version of the Symptom Checklist-90 (SCL-90). Some examples of items on this 
measure are: During the past seven days, including today, how much were you distressed by feeling 
suddenly scared for no reason; feeling tensed or keyed up; feeling nervous when you are left alone? 
Respondents indicate the extent to which each of the 53 problems on the checklist has caused distress 
over the past 7 days. The BSI uses a 5-point Likert response scale, ranging from (0) not at all to (4) 
extremely for each item. The measure evaluates nine primary symptom dimensions: depression, 
interpersonal sensitivity, anxiety, phobic anxiety, paranoid ideation, somatization, obsessive-compulsive, 
hostility, and psychoticism. The BSI provides a score of overall mental health functioning called the 
Global Severity Index (GSI), which provides information on the number of symptoms and intensity of 
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perceived distress of the individual using the mean of the nine subscale scores.  The GSI score was used 
for analyses in this study. Research indicates it is a useful measure of psychological functioning exhibited 
during inpatient and outpatient treatment for both males and females (Allen, Coyne, & Huntoon, 1998).  
For this study, the Cronbach’s alpha coefficient of reliability is α= .956.   
Social Support - Social support was measured using the Social Support Survey Instrument (SSSI; 
Sherbourne & Stewart, 1991). The SSSI is an 18-item brief, multidimensional, self-report survey of social 
support.  The SSSI consists of four separate subscales: emotional, tangible, affectionate, and positive 
social interaction.  The emotional subscale consists of eight items that relate to guidance and appraisal.  
The tangible support subscale consists of four items that relate to material support, aid, and reliable 
alliance.  The affectionate subscale consists of three items that relate to attachment and affect.  The 
positive social interaction subscale consists of four items that relate to social integration, belonging, and 
social companionship. Some examples of items on this measure are: How often is each of the following 
kinds of support available to you – someone you can count on to listen to you when you need to talk 
(emotional subscale); someone to take you to the doctor if you needed it (tangible subscale) someone 
who shows you love and affection (affectionate subscale); someone to do something enjoyable with 
(positive social interaction subscale)? The SSSI also provides a measure of overall social support using a 
mean score for all 18 items.  The overall social support score will be used for analyses in this study.  
Respondents indicate how often each of the 18 types of support is available to them.  The SSSI uses a 5-
point Likert response scale, ranging from (0) none of the time to (4) all of the time for each item. For this 
study, the Cronbach’s alpha coefficient of reliability is α= .967. 
Analytic Plan 
 This study attempted to determine whether three independent variables related to psychosocial 
functioning (traumatic stress experiences, mental health symptom severity, and prosocial support) had 
an effect on drug court graduation (completion or non-completion), when demographic characteristics 
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(age, gender, level of education, and employment) were held constant.  Logistic regression was 
considered the preferred statistical technique for this type of outcome-based dependent variable, as 
this method regresses a binary (dichotomous) dependent variable on an independent variable or set of 
variables to produce an estimate of the odds, or “the relative probability of falling into one of two 
categories” (Menard, 1995, p.12).  Studies using logistic regression commonly begin analyses with 
bivariate correlations to determine which variables contribute to model fit. Hosmer and Lemeshow 
(2010) presented this method as an adequate technique for analyses involving a binary outcome 
because eliminating unproductive variables increases overall model fit.  Logistic regression models using 
a forward stepwise method will be utilized to answer hypotheses related to the links between 
psychosocial factors and drug court graduation.  The use of stepwise methods is debated in the 
literature (see Hosmer & Lemeshow, 1989; Mundry & Nunn, 2009), but is deemed acceptable when the 
purpose of the research is the identification of predictors (Hosmer & Lemeshow, 1989; Menard, 2010).    
All statistical analyses in this study will be conducted using SPSS version 20 for Windows (SPSS, 2012).  
All statistical tests will be two-tailed, with statistical significance determined based upon an alpha level 
of 0.05.  Even though the hypotheses are not multidirectional, it would be overly confident to assume 
that the hypotheses are correct and it must be considered that the direction could be the opposite.  By 
using two-tailed tests, the probability is calculated from both tails and the possibility of missing an effect 
in the other direction is eliminated (BMJ, 1994; Hillenmeyer, 2006; UCLA, 2009).     
Research Question 1 
Logistic regression was utilized to assess first if there was a relationship between demographic 
variables (age, gender, level of education, and employment status) and drug court graduation (program 
completion vs. non-completion).  Each of the four demographic variables was entered as steps of the 
regression to determine whether demographics contribute to the prediction of drug court graduation. 
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Research Question 2 
 Logistic regression was utilized to assess next if there was a relationship between traumatic 
stress and drug court graduation (program completion vs. non-completion) while controlling for 
demographic variables (age, gender, level of education, and employment status). The demographic 
variables were entered as covariates into the first step of the regression. The predictor variable 
(traumatic stress) was entered into the second step of the regression along with the demographic 
variables to determine whether traumatic stress contributes to the prediction of drug court graduation 
over and above what demographic covariates account for. 
Research Question 3 
 Logistic regression was utilized to assess whether there was a relationship between mental 
health symptom severity and drug court graduation (program completion vs. non-completion) while 
controlling for demographic variables (age, gender, level of education, and employment status).  The 
demographic variables were entered as covariates into the first step of the regression. The predictor 
variable (mental health symptom severity) was entered into the second step of the regression along 
with the demographic variables.  
Research Question 4 
Logistic regression was utilized to assess finally whether there was a relationship between 
prosocial support and drug court graduation (program completion vs. non-completion) while controlling 
for demographic variables (age, gender, level of education, and employment status).  The demographic 
variables were entered as covariates into the first step of the regression.  The predictor variable 
(prosocial support) was entered into the second step of the regression along with the demographic 
variables. 
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Chapter 5:  Results 
 The purpose of this study was to examine the relationships between demographic 
characteristics and psychosocial factors of drug court participants and successful or unsuccessful drug 
court graduation.  First, bivariate analyses were conducted to determine the relationships among all of 
the variables included in the study.  Logistic regression was then conducted to examine the effects of 
the demographic covariates and independent variables on the dependent variable of drug court 
graduation. 
 Bivariate Analyses  
 Table 5 presents descriptive information for the sample according to drug court graduation 
status.  T-tests and Chi-squares were calculated to determine differences between the group that 
graduated and the group that did not graduate from the drug court program. Although participants in 
this study demonstrated no marked differences across categories of age and employment according to 
drug court graduation status (completed vs. did not complete), there was a statistically significant 
difference in regard to level of education. As depicted in Table 5, for participants who graduated drug 
court, the majority had completed at least some college (55.9%) by the time of the study.  In contrast, 
among those participants who did not graduate from drug court 45.5% reported less than high school as 
their highest level of education and only 22.7% reported some college or more.  Differences between 
graduates and non-graduates on scale scores of the independent variables assessing mental health 
symptom severity, social support, and traumatic stress were not statistically significant.  However, 
differences in scores on social support, particularly the subscale of affectionate support, and traumatic 
stress were approaching significance. The small size of the sample may have some bearing on this, in 
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that a larger sample size may have produced statistically significant results at the .05 level; future 
research should attempt to examine these questions with a larger sample size.  The descriptive statistics 
produced an interesting finding in terms of gender with female drug court clients being unsuccessful in 
terms of drug court graduation in only eight out of forty four cases (9%) compared to male drug court 
clients who were not successful in fourteen out of forty six cases (31%).   
Table 5. Descriptive Statistics for Selected Sample by Drug Court Graduation 
 
Total Sample 
(N=90) 
Graduated  
(N = 68) 
Did Not Graduate 
(N = 22) 
Significance 
Mean 
or N 
SD or % Mean 
or N 
SD or % 
C
o
va
ri
at
e
s 
Age 28.56 8.367 26.18 4.404 t(88) =1.273, p = .206 
Gender 
   Female 
   Male 
 
36 
32 
 
53% 
47% 
 
8 
14 
 
36% 
64% 
X2(1) = 1.828, p = .176 
  
 
 
 
 
  
Education 
    LT HS 
    HS 
    GT HS 
 
12 
18 
38 
 
17.6% 
26.5% 
55.9% 
 
10 
7 
5 
 
45.5% 
31.8% 
22.7% 
X2(2) = 9.254, p = .010* 
Employment 
    Unemployed 
    Employed 
 
42 
26 
 
61.8% 
38.2% 
 
14 
8 
 
63.6% 
36.4% 
X2(1) = 0. 025, p = .875 
IV
 
Brief Symptom Inventory 
– Global Scale Index (IV) 
0.73 0.53 0.74 0.60 X2(88) = -.071, p = .944 
Social Support Survey 
Instrument - Overall (IV) 
3.87 0.90 3.44 1.09 X2(88) = 1.841, p = .069 
Social Support Survey 
Instrument – Emotional 
Support Subscale(IV) 
3.76 .98 3.30 1.11 X2(88) = 1.852, p = .067 
Social Support Survey 
Instrument – Tangible 
Support Subscale(IV) 
3.92 1.12 3.70 1.26 X2(88) = .809, p = .421 
Social Support Survey 
Instrument – 
Affectionate Support 
Subscale(IV) 
4.12 1.03 3.60 1.31 X2(88) = 1.945, p = .055 
Social Support Survey 
Instrument – Positive 
Social Interaction 
Subscale (IV) 
3.82 1.12 3.32 1.21 X2(88) = 1.803, p = .075 
TSS (IV) 4.16 4.33 2.27 3.99 X2(88) = 1.813, p = .073† 
 *p <.05   
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In addition to examining the relationships between graduation status and each demographic 
and psychosocial variable, correlation coefficients were calculated to examine the relationships among 
all the demographic covariates, independent variables, and dependent variable in this study.  Bivariate 
correlations shown in Table 6 indicated positive correlations between gender and two of the three other 
demographic covariates (education and employment) and one of the three independent variables 
(mental health symptom severity). Female drug court participants were more likely to have higher levels 
of education (r = .210, p < .05) and to be employed (r = .441, p < .01) than male drug court participants. 
Higher scores on the BSI, which are indicative of higher mental health symptom severity (r = .288, p <. 
05), were associated with MADCT participants who were female.  Results indicated a negative 
correlation between social support and mental health symptom severity (r = -.224, p <. 05).  Further 
analysis shows that mental health symptom severity is negatively correlated with the subscales of 
tangible support (r = -.230, p < .05) and positive interaction (r = -.232, p < .05). The only variable 
associated with drug court graduation was education; results indicate that those with higher levels of 
education were more likely to successfully graduate from drug court (r = .321, p < .01).  Although none 
of the bivariate results produced significant findings in terms of the impact of the independent variables 
on drug court graduation, multivariate analyses were conducted for these complex research questions 
to determine if further or possibly contradictory results were found.  Researchers have indicated that 
discrepancies among univariate, bivariate, and multivariate statistics where a variable is not significant 
in the first set of analyses, but becomes significant in the next can be accounted for by: effects of 
unbalanced sample size, missing data influences, considerable within-group variation compared to 
between-group variation, and the presence of interaction (Lo, Li, Tsou, & See, 1995).   
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               Table 6. Bivariate Correlations Study Variables 
Variables 1 2 3 4 5 6 7a 7b 7c 7d 7e 
D
e
m
o
 
1. Age             
2. Gender  
(Female) 
.137            
3. Education .137 .210*           
4. Employment .164 .441** -.114          
In
d
e
p
e
n
d
en
t 
V
ar
ia
b
le
s 
5. Mental Health 
Symptom Severity 
(GSI/BSI) 
.072 .288** -.013 .319**         
6. Traumatic Stress 
Experiences (TSS) 
.126 .141 .020 .160 .141        
7a. Social Support  -.120 
 
-.059 
 
-.011 
 
-.053 
 
-.224* 
 
-.080        
     b. Emotional  
         Subscale 
-.063 
 
-.025 
 
.018 
 
-.038 
 
-.181 
 
-.128 
 
.907**      
     c. Tangible  
          Subscale 
-.262* 
 
-.075 
 
-.026 
 
-.016 
 
-.230* 
 
-.088 
 
.824** .596**     
     d. Affectionate    
         Subscale 
-.056 
 
-.023 
 
-.005 
 
-.111 
 
-.183 
 
-.017 
 
.904** .727** .748**    
     e. Positive  
          Subscale 
-.072 
 
-.106 -.028 -.077 -.232* .025 .862** .666** .663** .815**   
D
V
 8. Graduation  .134 .143 .321** -.017 -.008 .190 .193 
 
.194 
 
.086 
 
.203 
 
.189 
                                           *p <.05  ** p < .01 
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Multivariate Analyses 
Research Question 1 
Logistic regression was conducted to assess if there was a relationship between demographic 
variables (age, gender, level of education with “greater than high school” as the reference category, and 
employment status) and drug court graduation (program completion vs. non-completion).  When all 
four demographic variables were used to predict graduation (see Table 7), only education remained a 
significant predictor, net of all other factors. Specifically, the exp (b) of .190 indicates that those with 
more than a high school education (the reference category) are 1.000/0.190 = 5.26 times more likely 
than those with less than a high school education to graduate from drug court. Those with a high school 
education only were not significantly different from those with more than a high school education in 
their graduation rate, after controlling for age, gender, and employment. Further, neither age nor 
gender nor employment significantly influenced the probability of graduation from drug court. Together, 
these demographic covariates account for about 16.8% of the variance in the probability of drug court 
graduation.  Despite education being the only significant demographic predictor of drug court 
graduation, all demographic variables will be controlled for in each regression model to reduce any 
effects of variation for each research question. 
Table 7. Logistic regression analysis testing the effect of demographic variables on drug court graduation 
Independent Variable B SE p Wald df Exp (B) 
Age .036 .039 .358 .846 1 1.037 
Gender (male) -.478 .612 .435 .609 1 .620 
Education: Less than High 
School (versus More than HS) 
-1.660 .670 .013* 6.130 1 .190 
Education: High School Only 
(versus More than HS) 
-.955 .663 .149 2.078 1 .385 
Employment (employed) .207 .627 .742 .808 1 1.230 
*p <.05; R2=.168 
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Research Question 2 
 A logistic regression analysis was conducted next to test the hypothesis that drug court clients 
with higher levels of traumatic stress experiences would have less successful drug court outcomes in 
terms of graduation.  Demographics were controlled for by entering the covariates in Step 1 of the 
logistic regression.  The independent variable, traumatic stress, was entered in Step 2. The Hosmer and 
Lemeshow test of model fit showed a good model fit X2 (8) = 6.382, p = .605. As Table 8 demonstrates, 
the results of the final model (Wald = 2.907, p=.088) suggest that higher levels of traumatic stress 
experiences did not affect drug court graduation.  Nagelkerke’s R square showed that traumatic stress 
combined with demographics accounted for 21.4% of the total variance as compared to 16.8% in step 1 
with only the demographic covariates entered.   
Table 8. Logistic regression analysis testing the effect of traumatic stress on drug court graduation 
controlling for demographics (using TSS as measure of trauma) 
Independent Variable B SE p Wald df Exp (B) 
Age .031 .039 .423 .643 1 1.031 
Gender (male) -.516 .620 .406 .692 1 .597 
Education: Less than High 
School (versus More than HS) 
-1.722 .677 .011* 6.474 1 .179 
Education: High School Only 
(versus More than HS) 
-1.010 .670 .132 2.271 1 .364 
Employment (employed) .340 .641 .596 .692 1 .405 
Traumatic Stress Scale .114 .067 .088 2.907 1 1.121 
*p <.05   : R
2
 = .214 
Considering that perhaps this null result was due to the manner in which the TSS is scored, the 
variable was recoded from a continuous variable to a categorical variable based on the cut off scores 
provided by the authors of the measure that indicate low/no, moderate, or high traumatic stress 
experience.  Figure 1 illustrates that the variables are not normally distributed regardless of how the 
variable is measured; logistic regression does not require the variables to be normally distributed, just 
the error terms (Burns & Burns, 2008).  Logistic regression was run again (see Table 9) with the re-coded 
variable. Although the Hosmer and Lemeshow test of model fit showed a good model fit X2 (8) = 7.143, p 
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= .521, the influence of this alternative measure of traumatic stress on drug court graduation after 
controlling for demographics was not statistically significant.  Nagelkerke’s R square showed that this 
measure of traumatic stress combined with demographics accounted for 22% of the total variance in the 
probability of drug court graduation.   
A further consideration as to why the effect of traumatic stress on graduation was not 
significant was that perhaps the measure of trauma, which relied on memories of past events, was too 
far removed in time from graduation status.  Participants in the study also completed the Posttraumatic 
Stress Disorder Checklist- Civilian Version at baseline (PCL), which consists of 17 items that indicate how 
much distress a trauma symptom has caused in the past 30 days. For this study, the Cronbach’s alpha 
score for the PCL measure was α =.91.  An additional logistic regression analysis (see Table 10) was 
conducted to test the hypothesis that drug court clients with higher levels of traumatic stress 
experiences would have less successful drug court outcomes in terms of graduation.  Demographics 
were controlled for by entering the covariates in Step 1 of the logistic regression.  The independent 
variable, traumatic stress as measured by the PCL, was entered in Step 2. The Hosmer and Lemeshow 
test of model fit showed a good model fit X2 (8) = 3.846, p = .871.  The results again suggested that 
higher traumatic stress experiences, as measured by the PCL, did not have an influence on successful 
drug court graduation.  Nagelkerke’s R square showed that the model including demographics and the 
PCL measure accounted for only 18% of the total variance in drug court graduation.   
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Figure 1.  Comparison of Distribution of Trauma Scores 
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Table 9. Logistic regression analysis testing the effect of traumatic stress on drug court graduation 
controlling for demographics (using TSS Revised as measure of trauma) 
Independent Variable B SE p Wald df Exp (B) 
Age .027 .039 .485 .487 1 1.028 
Gender (male) -.459 .619 .458 .550 1 .632 
Education: Less than High 
School (versus More than HS) 
-1.655 .676 .014* 5.999 1 .191 
Education: High School Only 
(versus More than HS) 
-1.004 .672 .135 2.230 1 .366 
Employment (employed) .364 .640 .570 .322 1 1.438 
Traumatic Stress Scale 
Revised 
.573 .315 .069 3.301 1 1.773 
*p <.05; R2=.220 
 
 
Table 10. Logistic regression analysis testing the effect of traumatic stress on drug court graduation 
controlling for demographics (using PCL as measure of trauma) 
Independent Variable B SE p Wald df Exp (B) 
Age .032 .039 .414 .667 1 1.033 
Gender (male) -.636 .650 .328 .956 1 .529 
Education: Less than High 
School (versus More than HS) 
-1.680 .674 .013* 6.221 1 .186 
Education: High School Only 
(versus More than HS) 
-.979 .666 .141 2.166 1 .376 
Employment (employed) .061 .655 .926 .009 1 1.063 
Posttraumatic Stress Checklist -.022 .025 .372 .795 1 .978 
*p <.05; R2=..180 
 
 
Research Question 3 
A logistic regression analysis was conducted next to test the hypothesis that drug court clients 
with higher levels of mental health symptom severity would have less successful drug court outcomes in 
terms of graduation.  Demographics were controlled for by entering the covariates in Step 1 of the 
analysis.  The independent variable, mental health symptom severity, was entered in Step 2. The 
Hosmer and Lemeshow test of model fit showed a good model fit X2 (8) = 4.965, p = .761. As Table 11 
demonstrates, the results of the final model (Wald = .075, p=.784) suggest that higher levels of mental 
health symptom severity did not affect drug court graduation.  Nagelkerke’s R square showed that 
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mental health symptom severity combined with demographics accounted for 16.9% of the total variance 
as compared to 16.8% in step 1 with only the demographic covariates entered.  
Table 11. Logistic regression analysis testing the effect of mental health symptom severity on drug court 
graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .036 .039 .355 .856 1 1.037 
Gender (male) -.519 .633 .412 .672 1 .595 
Education: Less than High 
School (versus More than HS) 
-
1.651 
.671 .014* 6.054 1 .192 
Education: High School Only 
(versus More than HS) 
-.964 .664 .146 2.110 1 .381 
Employment (employed) .182 .635 .775 .082 1 1.199 
Mental Health Symptom 
Severity 
-.147 .536 .784 .075 1 3.561 
*p <.05; R2= .169 
 
Research Question 4 
A logistic regression analysis was conducted next to test the hypothesis that drug court clients 
with higher levels of access to prosocial support would have more successful drug court outcomes in 
terms of graduation.  Demographics were controlled for by entering the covariates in Step 1 of the 
logistic regression. The independent variable, access to prosocial support systems (Overall Social 
Support), was entered in Step 2.  The Hosmer and Lemeshow test of model fit showed a good model fit 
X2 (8) = 4.965, p = .761.  As Table 12 demonstrates, the results of the final model (Wald = .378, p=.036) 
suggest that higher levels of access to prosocial support systems did have a relationship with drug court 
graduation.  Nagelkerke’s R square showed that this variable accounted for 23.4% of the total variance 
as compared to 16.8% in step 1 with only the demographic covariates entered.  The results indicate 
some support for the notion that individuals with higher levels of access to prosocial support systems 
are more likely to successfully graduate from drug court.  
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Table 12. Logistic regression analysis testing the effect of access to prosocial support on drug court 
graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .044 .039 .261 1.262 1 1.045 
Gender (male) -.657 .643 .307 1.044 1 .519 
Education: Less than High 
School (versus More than 
HS)Education: More than 
High School versus Less than 
High School 
-1.984 .696 .016* 5.847 1 .186 
Education: High School Only 
(versus More than HS) 
-1.203 .697 .084 2.979 1 .300 
Employment (employed) .286 .653 .661 .192 1 1.331 
Overall Social Support  .607 .290 .036* 4.378 1 1.835 
*p <.05; R2=.234 
 
To further explore the relationship between prosocial support and drug court graduation, 
additional analyses were conducted using the separate scales of the Social Support Survey Instrument to 
determine which type of support had the greatest influence on drug court graduation. In separate 
models, the overall scale was replaced by adding in each subscale. Table 13 shows the results of logistic 
regression analysis using the emotional support subscale of the Social Support Survey Instrument in the 
second step of the model; the demographic covariates were entered in the first step.  The Hosmer and 
Lemeshow test of model fit showed a good model fit for the overall model X2 (8) = 8.725, p = .366.   The 
results of the final model using the first subscale, Emotional Support (Wald 3.834, p = .050), suggest that 
higher levels of access to emotional support was moderately related to successful drug court 
graduation, net of the effects of demographic characteristics.  Nagelkerke’s R square showed that this 
variable, along with the demographic variables, accounted for 22.5% of the total variance as compared 
to 16.8% in step 1 with only the demographic covariates entered.    
An additional logistic regression was conducted for the second subscale of the SSSI.  As Table 14 
demonstrates, the Tangible Support subscale of the SSSI was not a significant predictor of drug court 
graduation (Wald 1.703, p = .192) when demographic variables were controlled. Nagelkerke’s R square 
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showed that this model accounted for 19.3% of the total variance as compared to 16.8% in step 1 with 
only the demographic covariates entered. 
Table 15 shows the results of logistic regression analysis using the Affectionate Support subscale 
of the SSSI.  The results of the final model using this scale (Wald.158, p = .041) suggest that higher levels 
of access to affectionate support was related to successful drug court graduation, controlling for 
demographic variables.  Nagelkerke’s R square showed that this model accounted for 23.1% of the total 
variance as compared to 16.8% in step 1 with only the demographic covariates entered. 
A final logistic regression was conducted with the last subscale of the SSSI, Positive Social 
Interaction.  As Table 16 demonstrates, the results of the final model (Wald = 4.413, p = .036), suggest 
that higher levels of access to positive social interaction is related to successful drug court graduation, 
controlling for demographics.  Nagelkerke’s R square showed that this variable, along with the 
demographic variables, accounted for 23.5% of the total variance as compared to 16.8% in step 1 of the 
model with only the demographic covariates entered. 
Table 13. Logistic regression analysis testing the effect of the emotional support subscale of the Social 
Support Survey Instrument on drug court graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .039 .039 .318 .995 1 1.040 
Gender (male) -.601 .628 .339 .913 1 .549 
Education: Less than High 
School (versus More than HS) 
-1.663 .693 .016* 5.760 1 .190 
Education: High School Only 
(versus More than HS) 
-1.164 .697 .095 2.791 1 .312 
Employment (employed) .262 .641 .683 .167 1 1.300 
Emotional Support Subscale .527 .269 .050* 3.384 1 1.694 
*p <.05; R2=.225 
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Table 14. Logistic regression analysis testing the effect of the tangible support subscale of the Social 
Support Survey Instrument on drug court graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .048 .040 .228 1.450 1 1.09 
Gender (male) -.592 .630 .347 .883 1 .553 
Education: Less than High 
School (versus More than HS) 
-
1.643 
.677 .015* 5.987 1 .193 
Education: High School Only 
(versus More than HS) 
-
1.052 
.676 .120 5.888 1 .349 
Employment (employed) .304 .643 .637 2.423 1 1.355 
Tangible Support Subscale .313 .240 .192 1.703 1 1.368 
*p <.05; R2=.193 
 
Table 15. Logistic regression analysis testing the effect of the affectionate support subscale of the Social 
Support Survey Instrument on drug court graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .040 .040 .313 1.019 1 1.041 
Gender (male) -.513 .635 .420 .651 1 .599 
Education: Less than High 
School (versus More than HS) 
-
1.734 
.700 .013* 6.131 1 .177 
Education: High School Only 
(versus More than HS) 
-
1.229 
.696 .077 3.120 1 .293 
Employment (employed) .137 .653 .834 .044 1 1.147 
Affectionate Support Subscale .493 .242 .041* 4.158 1 1.637 
*p <.05; R2=.231 
 
Table 16. Logistic regression analysis testing the effect of the positive social interaction subscale of the 
Social Support Survey Instrument on drug court graduation controlling for demographics 
Independent Variable B SE p Wald df Exp (B) 
Age .042 .041 .299 1.077 1 1.043 
Gender (male) -.709 .659 .282 1.160 1 .492 
Education: Less than High 
School (versus More than HS) 
-
1.699 
.696 .015* 5.956 1 .183 
Education: High School Only 
(versus More than HS) 
-
1.145 
.685 .095 2.793 1 .318 
Employment (employed) .277 .664 .677 .174 1 1.319 
Positive Social Interaction 
Subscale 
.504 .240 .036* 4.413 1 1.656 
*p <.05; R2=.235 
 
  
60 
 
Summary of Results 
To answer the four research questions presented in this study, logistic regression analysis was 
conducted to examine the impact of three independent variables, traumatic stress, mental health 
symptom severity, and prosocial support on drug court graduation, controlling for four demographic 
variables: age, gender, education, and employment. Prosocial support was further examined by four 
subscales: emotional support, tangible support, affectionate support, and positive social interaction. The 
results demonstrated that the majority of the demographic covariates were not predictors of drug court 
graduation.  However, a higher level of education, specifically having at least some college, was found to 
be associated with successful completion of medication-assisted drug court treatment when compared 
to those participants who had less than a high school education.   
Research question two examined the relationship between traumatic stress experiences at 
baseline and the dependent variable of drug court graduation and found no significant relationship.  
Additional regression analyses were conducted using a recoded variable and an alternative measure of 
trauma and results were still insignificant.  
 Research question three examined the relationship between mental health symptom severity at 
baseline and drug court graduation; the relationship was not significant.  Research question four 
examined the relationship between access to prosocial support at baseline and drug court graduation; 
the results were significant.  Additional logistic regression analyses were conducted to examine different 
types of prosocial support using the subscales of the measure and found that emotional support, 
affectionate support, and positive social interaction were significantly related to drug court graduation, 
whereas tangible support had no impact on drug court graduation. The implications of these results are 
addressed in the discussion. 
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Chapter 6: Discussion 
 The study of drug court processes and outcomes has garnered increased attention within the 
research literature (Belenko, 2001; Dannerbeck, Harris, Sundet, & Lloyd, 2006; Finigan, 2009; Mitchell, 
Wilson, Eggers, & MacKenzie, 2012; Zweig, et al., 2011). To expand consideration of the factors that 
influence drug court graduation, this dissertation examined three independent variables deemed 
relevant to graduation from medication-assisted drug court treatment. This study explored the 
association of trauma experiences, mental health symptoms, and social support, while controlling for 
four demographic variables (age, gender, employment, and level of education), with drug court 
graduation.  Evaluations of drug court outcomes have provided evidence that participation in such 
programs is beneficial for society and offenders in terms of recidivism, relapse, and related cost savings 
(King & Pasquarella, 2009; Marlowe, 2010; Rossman, Roman, Zweig, Rempel, & Lindquist, 2011; Sechrest 
& Shichor, 2001: Taxman & Bouffard, 2002 ).  However, the majority of outcome studies have focused 
on structural-level processes within the court system that produce these effects with little examination 
of individual-level effects.  In particular, investigation of psychosocial factors remains largely unexplored.  
Furthermore, research examining opioid offenders and medication-assisted treatment within drug 
courts is scarce, despite rapidly increasing rates of the nonmedical use of prescription drugs. This 
research adds to the literature on drug courts, as well as to the literature on nonmedical use of 
prescription drugs, by including measures of psychosocial factors in an analysis of drug court graduation 
among medication-assisted drug court treatment clients.  The results of this analysis indicate that pre-
program factors in terms of certain demographic characteristics (education level) influence successful 
drug court completion and that social support is an important predictor of drug court graduation. 
62 
 
However, the effects of other demographic characteristics (age and employment) and psychosocial 
factors (trauma and mental health symptoms) had no impact on drug court graduation. 
Demographic Variables – Findings and Implications 
 The first research question of this study focused on describing the demographic characteristics 
of the sample in terms of age, gender, education level, and employment at baseline assessment in 
comparison to drug court graduation.  The literature documents these factors as being predictive of 
drug court outcomes, albeit with inconsistent results.  Previous research findings have supported the 
suggestion that younger drug court clients are less likely to successfully complete drug court programs 
(Dannerbeck, Harris, Sundet, & Lloyd, 2006; Hickert, Boyle, & Tollefsen,2009; Logan, Williams, Leukefeld, 
& Minton, 2000;  Saum, Scarpitti, & Robbins, 2001), while another study found that younger participants 
were more likely to graduate (Senjo & Leip, 2001).  Others researchers found no age effect (Gray & 
Saum, 2005; Miller & Shutt, 2001). The average age of drug court clients in this sample was 28 for those 
participants who graduated and 26 for those who did not graduate; this is consistent with national rates 
that found mean ages (when reported) between 28 and 33 (Brown, 2010) .  Consistent with some 
research findings (Roll, Pendergast, Richardson, Burdon, & Ramirez, 2005; Schiff &Terry, 1997), age was 
not a significant predictor of drug court graduation in this study and was not correlated with the other 
variables in the study. 
 Within the criminological research, there is the theoretical notion of a developmental course of 
criminal behaviors with some researchers positing the existence of career criminals (Blumstein& Cohen, 
1979; Piqero, Farrington, & Blumstein, 2003), others differentiating life course persistent versus 
adolescent limited offending behaviors (Moffitt, 1993, 1994), and still others stating that all offenders 
will eventually age out of criminality (Hirschi and Gottfredson, 1983; Sampson & Laub, 2003). The only 
consensus as to the age-crime relationship is that there seems to be some type of both individual-level 
and contextual-level correlates operating to continue with or desist from further criminal behavior and 
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that examining within-individual continuity over time is important to understand this relationship 
(Loeber,  Farrington, Stouthamer-Loeber, Moffitt, & Caspi, 1998; Moffitt & Caspi, 2001; Sampson & 
Laub, 2003).  Comparable to the criminological literature, a tangible method through which age could be 
operating on drug court graduation is unclear from the larger body of drug court research and 
impossible to determine from the results of this study.  The lack of an effect from age could be due to 
the small amount of variation in age among clients in this particular drug court.  Given the inconsistent 
findings within drug court research for age as a predictor of drug court graduation, research should 
continue to examine this factor, particularly in relation to other variables and with a stronger theoretical 
background to determine links.  Moreover, longitudinal studies of long-term recidivism and relapse rates 
after drug court graduation are scarce within the literature and this type of study could better explain 
age effects.   
 Another perspective on the age-crime relationship within the criminological literature is that of 
Sampson and Laub (1993), who suggested that the association is a function of participation within 
conventional institutions within society, such as marriage and employment. Future studies should 
consider if an age effect is present while controlling for other individual and contextual level factors.  
Furthermore, age is in important factor in the nonmedical use of prescription drugs, with younger 
individuals more likely to misuse and abuse pharmaceuticals than older individuals (Herman-Stahl, 
Krebs, Kroutil, & Heller, 2007). Further research should examine age as a factor among NMPDU 
populations and how that might impact use patterns, criminal justice experiences, and treatment 
outcomes. For example, within the criminological literature, Ford & Schroeder (2009) examined NMPDU 
in a college sample and identified general strain theory as supporting findings of use patterns; future 
studies should expand on this and apply criminological theory to recent trends in drug use and crime to 
better explain drug court outcomes.  A stronger theoretical examination of pathways of the drug-crime 
relationship in reference to NMPDU could have important practical benefits in terms of criminal justice 
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processing, i.e., assessing risk and protective factors for criminal behavior could impact alternative to 
sentencing programs and treatment options within a drug court framework. 
 In addition to examining age as a demographic factor predictive of drug court graduation, the 
role that gender plays in successful drug court treatment was also explored in this study.  Bivariate 
results indicated a gendered effect in terms of drug court graduation, with more women successfully 
completing the program than men; however, when other demographic factors were controlled for in the 
statistical model, this finding was no longer relevant.  Within the drug court literature, findings are again 
mixed in terms of the effect of gender on graduation.  Some research suggests that female drug court 
participants have better outcomes than male participants (Gray & Saum, 2005; Dannerbeck, Harris, 
Sundet, & Lloyd, 2006 Hartman, Johnson Listwan, & Koetzle Shaffer, 2007), while others have found no 
differences between male and female participants in terms of drug court outcomes (Brown et al., 2011; 
Evans et al., 2009; Peters et, al., 1999; Rempel et, al., 2003; Young & Belenko, 2002).  Some studies have 
indicated that female drug court participants are more motivated to complete treatment than their 
male counterparts and others have suggested that women experience unique external factors that 
influence drug court graduation, such as the threat of losing custody of their children (Dakof et, al.,2010; 
Webster et al., 2006), childcare issues that impact treatment (Butzin, Saum, & Scarpitti, 2002), and lack 
of specific services directed at women (Schaffer, Hartman, & Listwan, 2009).  
  Feminist perspectives within the criminological literature propose gendered pathways of crime 
and deviance, which in turn affect rehabilitative outcomes.  Daly (1994) proposes five pathways to crime 
for women, all of which incorporate psychosocial factors: street women characterized by extensive 
criminal histories, abusive childhoods, lower levels of education, and involvement in the welfare system 
(Daly, 1994 Morash, 2006), harmed/harming women characterized by experiences of physical and/or 
sexual abuse and/or neglect, with related psychological problems and a lack of coping skills that lead to 
substance abuse and violence (Daly, 1994; Morash, 2006); battered women characterized by limited 
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criminal histories with substance abuse often preceded by traumatic experiences (Daly, 1994; Leverentz, 
2006; Morash, 2006); drug-connected women characterized by substance abuse that is highly impacted 
by their interpersonal relationships with men who lead them into drug use and crime (Daly, 1994; 
Morash, 2006); and economically motivated women characterized by criminal activities based on greed 
or poverty (Daly, 1994).  These pathways to criminal behavior for women could also impact treatment 
outcomes without specific programming that addresses their particular criminogenic risk and protective 
factors.  The literature on rehabilitative procedures and evidenced-based practices is slanted toward 
males with less attention given to the determination of effective interventions for female offenders 
(Belknap, 2007; Hubbard& Matthews, 2008; Palmer & Hollin, 2007).  An examination of gender-specific 
or gender-responsive needs could better explain gender effects of drug court graduation as well as their 
correlation with other variables.  Utilizing feminist perspectives within criminological theory to further 
study drug court clients could influence more research on gendered treatment programming and drug 
court outcomes. 
 Additional investigation of recent trends in the drug-crime relationship in regard to gender could 
yield more specific information important to recent trends in drug use patterns. The criminological 
literature notes that men commit more crime than women (Steffensmeier, 1996; Lauritsen, Heimer, & 
Lynch, 2009); however, women are more likely to be arrested for drug crimes than any other crime 
(Bloom, Owen, & Covington, 2005).  Furthermore, although men and women share some of the same 
traits in terms criminality, such as lower socioeconomic status, lower levels of education, and 
problematic interpersonal relationships (Liang & Long, 2013; Heimer, 2000), certain factors are more 
likely to predict criminal behavior among women than men (histories of abuse, trauma experiences, and 
mental health issues) (Belknap, 2001; Chesney-Lind & Pasco, 2004).  These gender-sensitive factors 
could also impact drug use patterns and treatment outcomes for women and require further 
investigation within the drug court literature.  Lastly, the literature on the role of gender and the 
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nonmedical use of prescription drugs indicated varied results (McCabe, Teter, Boyd & Knight, & 
Weschler 2005; Weyandt et al., 2009) and deserves further attention to assess the impact of gender on 
drug court graduation among this population  
 A recent meta-analysis of drug court outcomes indicated a relationship between employment 
and drug court performance (Zweig, et al., 2011).  The results of this study did not support this finding.  
Employment status did not significantly predict drug court graduation.  However, given research within 
the drug court literature as well as in the behavioral healthcare literature that indicates that this is an 
important factor in treatment outcomes, future studies should examine this factor to determine its 
utility in drug court programming.  The lack of an employment effect in this study could be a result of 
the participants having high levels of access to prosocial support systems; clients could be focusing on 
treatment while being supported in ways that negate an influence of employment status.    
 Similar to the other demographic variables studied, level of education and drug court outcomes 
demonstrate mixed findings in the research.  The majority of studies find a positive relationship 
between higher levels of education and drug court performance (DeMatteo et al., 2009; Hickert et. al, 
2009; Mullany & Peat, 2008; Shaffer et al., 2010; Schiff & Terry, 1997); the results of this study are 
consistent with these findings.  Drug court clients in this study with higher levels of education were 
more likely to graduate from drug court than those clients without a high school diploma. Some of the 
drug court literature has produced findings with no education effect (Senjo and Leip, 2001a; Hepburn & 
Harvey, 2007; Hiller et al., 1999), and future studies should examine whether controlling for other 
significant variables accounts for the discrepancies.  However, the education effect remained constant in 
this study even when other demographic factors were included in the model; nonetheless, other factors 
that were not included in these analyses could account for some variation.  For instance, criminological 
research demonstrates links between socioeconomic status and level of education that influences 
criminal behaviors and this association could influence this relationship among drug court clients.  
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Future studies should include socioeconomic status and criminal histories when examining level of 
education as a predictor of drug court outcomes.  
  It should be noted that race was not examined in this study due to insignificant variance for this 
demographic among the sample.  However, history has shown that certain criminal justice policies and 
rehabilitative correctional practices have led to disproportionate arrest rates and unequal access to 
resources for racial and ethnic minorities (and class and gender inequalities as well) (Lutze,& 
VanWormer, 2007) and drug court findings on race follow this trend. Within the drug court literature, 
numerous studies have examined the relationship between race and drug court outcomes and found 
significant differences between graduation rates of white and non-white drug court clients (Belenko, 
2001; Fradella, Fischer, Kleinpeter, & Koob, 2009; Hartley & Phillips, 2001).  Dannerbeck and colleagues 
(2006) found that white drug court clients were more likely to graduate from drug court (55%) than 
black drug court clients (28%).  Belenko’s (2001) meta-analysis on drug court outcomes also found that 
whites are more likely to have successful drug court outcomes than non-whites, but there is a lack of 
consensus in the literature as to why this race effect is found.  Race is an important topic within the 
drug-crime literature and should be further examined among drug court participants and NMPDU 
offenders in particular.  The “war on drugs” contributed to disproportionate arrest rates among black 
males for drug offenses (Beckett, Myrop, Pfingst, & Bowen, 2005; Beckett &  Sasson 2004; Blumstein, 
1993; Reinarman and Levine 1997). These patterns increase every year, yet the rates of black drug 
offenders participating in drug court programs remains historically lower than the rates of white 
participants (Fradella,Fischer, Kleinpeter, & Koob, 2009; Miller & Shutt, 2001; Sechrest & Shicor, 2001).  
Underlying factors related to social disorganization, racism and poverty, and pathways to drug of choice 
could be influencing criminal justice responses to black drug offenders. Individual-level predictors of 
drug use patterns (Baumer, 1994; Duster, 1997) and drug court participation (Dannerbeck,-Kanku, & 
Yan, 2009; Huebner & Bynum, 2008) could be tied to these types of contextual factors. Specifically, 
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neighborhood context and law enforcement attitudes about race, drugs, and crime (Goode, 2002) could 
be influencing participation rates.  Research on drug court outcomes has largely excluded contextual 
factors and this should be given more consideration in the literature.  Other confounding factors, such 
as criminal history, level of education, and employment, and their links to race, have influenced drug 
court outcomes (Belenko, 2001; Brewster, 2001; Schiff & Terry, 1997) and these issues should be further 
explored.  
 Demographic characteristics play an important role in drug court outcomes despite a lack of 
agreement among research findings (see Appendix A).  Further exploration of these factors could have 
important policy implications in terms of programming.  For instance, Payton and Gossweiler (1999) 
proposed that that a major problem among drug courts is the deficiency of specific, responsive 
programs in regard to race, gender, and mental illness; MAT could be added to this issue.  Drug court 
programs that set specific selection criteria, detail protocols for adjudication and treatment, and offer 
specialized means of supervision based on empirical findings in relation to individual level factors could 
dramatically change what we know about for whom drug courts work for and why. 
Independent Variables – Findings and Implications 
 In addition to an examination of demographic variables in this study, the prediction of drug 
court graduation among medication-assisted treatment clients was examined by means of trauma 
experiences, mental health symptoms, and access to prosocial support systems; the only effect found 
was that of social support.   The literature on psychosocial factors as being predictive of drug court 
outcomes is scarce despite an expansive body of literature that documents significant associations 
between trauma and mental health factors and substance abuse (Hawkins, Catalano, Miller, 1992; 
Hasin, Goodwin, & Stinson, 2005; Jacobsen, Southwick, & Kosten, 2001; Triffelman, 2003) and 
information that indicates high rates of mental health issues among on drug court participants (Cooper, 
1997; Dannerbeck, Sundet, & Lloyd, 2002; Hagedorn & Willenbring, 2003).  Additionally, the extant 
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literature demonstrates associations between improved treatment outcomes and social support 
(McLellan, Arndt, Metzger, Woody, & O'Brlen, 1993).  Information on MAT drug court participants is 
even less examined in the drug court literature, especially in regard to psychosocial factors as predictors 
of graduation.  There is, however, some research that examines psychosocial factors in relation to 
NMPDU, and results indicated that NMPDU was associated with social phobias, depression, and anxiety 
(Becker, Sullivan, Tetrault, Desai, & Fiellin, 2008).  Studies also found gendered effects for NMPDU, with 
women more likely to exhibit mental health symptoms than men (Brady, Back & Greenfield, 2009). 
 The aim of the second and third research questions for this study was to examine these 
particular psychosocial factors to determine their impact on drug court graduation.  The guiding 
hypotheses were that experiences of traumatic stress and mental health symptom severity would have 
a negative effect on drug court graduation.  However, statistical analyses found no significant 
relationship between trauma experiences or mental health symptoms of medication-assisted drug court 
treatment clients and drug court graduation. These results are inconsistent with prior research in this 
area, which indicates that these factors may impact treatment outcomes for both MAT and psychosocial 
protocols (George & Krystal, 2000).  The lack of an effect of these psychosocial factors on drug court 
graduation could be due to the limitation of using only baseline assessment data, meaning that changes 
could occur over time that influence graduation.  Another explanation is that the measures used in the 
study, particularly the TSS, are presented in a way that makes the import of the questions easy to 
determine, which increases the possibility of participants providing social acceptable or biased 
responses.   
 The lack of a trauma effect or a mental health effect could also be a function of the treatment 
program incorporating mental health services within addiction treatment to improve client outcomes.  
Lastly, there are more sophisticated measures of trauma available, and future research should examine 
more comprehensive measures for review.  Additional investigation should employ different measures 
70 
 
to substantiate or refute this study’s findings.  There are several explanations as to why a different 
trauma measure may account for the lack of significant results. First, the TSS measures symptoms 
related to past traumatic experiences within the last month, whereas participants at the baseline 
assessment may have been focused on their current criminal justice situation and/or current mental 
health issues and felt those factors to be a greater burden at the time than the way trauma had affected 
them in the past.  Secondly, it could be that assessing trauma and mental health symptoms in relation to 
drug court graduation is a more complex issue than a simple model measuring only current symptoms 
can account for.  A more sophisticated longitudinal model using more sensitive measures, such as a 
more comprehensive measure of trauma and/or qualitative methods, and a consideration of other 
factors such as therapeutic alliance (collaborative aspect of the counselor/client relationship) (Bordin, 
1979) in conjunction with these issues could better account for the nuances inherent in these types of 
interpersonal problems.  The literature strongly suggests that treatment outcomes are negatively 
influenced by traumatic experiences and mental health symptom severity; even though the findings of 
this study do not support the association between traumatic experiences and mental health issues, 
more studies should examine these issues within a drug court context and in connection with the drug-
crime relationship to expand our knowledge in these areas and to incorporate an interdisciplinary 
approach that integrates criminological research within a behavioral healthcare perspective.  For 
example, criminologists are beginning to investigate ways to interpret psychosocial factors in relation to 
nonmedical use of prescription drugs within existing criminological theories, such as general strain 
theory (Ford & Schroeder, 2008).  An examination of psychosocial factors that are specific to MAT and 
NMPDU is imperative as the results of a single study cannot determine the scope of this issue.  More 
research is needed to better account for drug court applications that incorporate growing trends of illicit 
drug use and its treatment. 
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 Criminology can contribute to this body of literature by incorporating factors related to 
substance abuse within existing theoretical frameworks in the same vein as Ford & Schroder (2008).  
General Strain Theory (GST) (Agnew, 1992, 1995, 2002, 2006) appears to offer a constructive theoretical 
framework for explaining the factors associated with individual experiences of strain and substance 
abuse.  The experience of strain (stressors or trauma) as discussed in GST can be thought of as a distal 
cause of crime; it is through the processes of mediation and conditioning that deviant or criminal 
behaviors ultimately occur (Piquero and Sealock, 2004).  Negative affect is presented as mediating the 
relationship between strain and crime, while other variables condition strain’s effect on crime.  The 
emotion of anger is principally related to criminal acts and emotions related to depressive and trauma 
related disorders for instance, despair and hopelessness, are related to deviant coping mechanisms such 
as the use of drugs and/or alcohol (Agnew, 1992, 2001, 2006).  GST allows for the examination of the 
stressors that may contribute to substance abuse and subsequent criminal behaviors surrounding 
substance abuse.  Further exploration of integrating criminological theory with behavior healthcare 
issues could lead to a better understanding of the impact of mental health on the drug-crime 
relationship. 
 The final research question in this study examined the relationship between access to prosocial 
support systems and drug court graduation.  Results indicated a significant association with higher levels 
of access to prosocial support predicting graduation.  Overall social support, emotional support, 
affectionate support, and positive social interaction were significantly related to drug court graduation, 
whereas tangible support had no impact on drug court graduation. These findings are consistent with 
the literature that demonstrates improved treatment outcomes for individuals with support systems 
available compared with those individuals who do not have these resources (Davis & Jason, 2005; El-
Bassel, Chen, & Cooper, 1998; Gearon, Nidecker, Bellack, & Bennett, 2003).  Research on social support 
and drug court outcomes are limited and this finding contributes to the literature in this area. Behavioral 
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healthcare research establishes a link between perceived social support and improvement in 
psychosocial functioning during treatment (Chong & Lopez, 2005; Laudet, Cleland, Magura, Vogel, & 
Knight, 2004; Warren, Stein, & Grella, 2007); this information is useful in adopting treatment strategies 
and drug court programming to improve client success.  Additional research on social support and drug 
court outcomes should investigate the relationships among perceived social support, therapeutic 
alliance, mental health symptoms, and traumatic stress experiences to determine if there are 
interactions between these variables. 
 Social support networks are featured in several criminological theories that propose a link 
between these associations and crime (Agnew, 1992; Akers, 1998; Capowich, Mazzerolle, & Piquero, 
2001; Cullen & Wright, 1997; Thornberry, Lizotte, Krohn, Farnworth, & Jang, 1994; Warr, 2002), but few 
studies directly discuss the concept of social support as a criminogenic factor.  For example, general 
strain theory (Agnew, 1992, 2000, 2002, 2006) implies that social support could prevent crime by 
mediating the effects of negative affect that causes criminal behavior.  In Sampson and Laub’s (1993) 
life-course theory of crime, social bonds are discussed as providing “divergent pathways” from crime 
(p.141).  Conversely, differential association theory (Sutherland, 1947 see for e.g. Williams & McShane, 
2004) and social learning theory (Akers, 2009) argue that criminal behavior is learned via social 
interactions.   
 Exploring social networks within the current trends of the drug-crime relationship could have 
important implications for drug-crime interventions.  Future research should examine the effects of 
social support on long-term recidivism and relapse as this determination could be important in providing 
a better understanding of the drug-crime relationship.  In fact, Francis Cullen proposed examining social 
support as an organizing concept within criminological theory in his presidential address to the Academy 
of Criminal Justice Sciences in 1994 (Cullen, 1994).  Cullen states “… in criminology the insights linking 
social support to crime remain disparate, and are not systematized so far as to direct theoretical and 
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empirical investigation” (p. 529 ). Unfortunately, almost 20 years later this remains the case.  Perhaps a 
governing research direction, such as social support within the drug-crime relationship and its 
subsequent outcomes can inspire the field to adopt Cullen’s proposed steps to include the study of 
social support within criminology. 
Limitations  
 This study has a number of limitations. The data were collected as part of an evaluation of a 
single drug court program; there was no comparison group against which the data could be weighed. 
Therefore, any conclusions generated by the outcomes of this study may apply only to this specific 
population with negligible generalizability to drug courts overall. However, there are very few drug 
courts utilizing medication-assisted treatment (MAT) and subsequently not much extant literature 
examining this population. A conventional drug treatment court or use of a mental health court as a 
comparison group would not have been feasible since these other types of courts would lack the MAT 
component.  
 Another issue with generalizability is the relatively small sample size. Participants in this type of 
drug court are rare, given the eligibility requirements. Further attrition from the sample caused by 
declining to participate in the study or by active ongoing participation in drug court treatment did not 
adversely affect the study, however. Analysis showed that the excluded sample (N=55) did not 
significantly differ in demographic characteristics from the included sample.  
 Another limitation was the use of only baseline measures to predict later drug court outcomes. 
Measurement of the independent variables at a single point in time cannot elucidate how drug court 
processes and treatment over time could affect outcomes.  Additionally, the use of secondary data 
analysis can be problematic due to data quality issues (Law, 2005). For example, one shortcoming of 
self-report data is that some participants may not have disclosed instances of trauma and mental health 
symptoms, limiting the validity and accuracy of the data.  
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 Finally, there were limitations in the statistical analysis regarding the treatment of non-normally 
distributed variables.  Even though there are no assumptions about the distribution of independent 
variables in logistic regression given that the focus is on the outcome variable (Agresti, 1996; Press & 
Wilson, 1978), statistical procedures could be applied that further address the skewed distribution of 
the data for trauma and mental health symptoms; trauma, in particular, had many zero values. 
Statistical techniques to transform the data, for instance the Box-Cox (1964) transformation, might have 
helped the data to obtain a more normal distribution using a mathematical method to check for the 
smallest standard deviation. In this statistical technique, all data are transformed to a certain exponent 
indicated by a Lambda value (Kim & Hill, 1993; Spitzer, 1982) and non-normally distributed data are 
transformed to approximate normal distribution (Riani & Atkinson, 2000).  This technique does not 
always work and requires all items under comparison be transformed in the same way (Lindsey & 
Sheather, 2010; Velilla, 1993).  Given the small sample size and issues with the manner in which trauma 
was measured, power transformation techniques were not applied. However, if further analyses are 
completed with this data, these techniques should be considered. 
Conclusion and Recommendations for Future Research 
 In conclusion, this study examined demographic characteristics and psychosocial attributes of 
participants who participated in medication-assisted drug court treatment.  The lack of significant 
findings for trauma and mental health effects may possibly be a function of not controlling for other 
significant variables; moreover, these data may not have sufficient measures of psychosocial factors, 
particularly trauma, that demonstrates the relationship.  Future studies on these issues would likely 
benefit from more comprehensive measures and more sophisticated analyses. The significant models 
found that higher levels of education and greater access to prosocial support were significant predictors 
of graduation.  Future research should continue to investigate these variables to better inform the 
literature on the practical implications of these findings. The graduation rate for the selected MADCT 
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sample was 76%, considerably higher than the national average of 51% (Huddleston and Marlowe, 2011) 
indicating a positive outcome for drug court clients in medication-assisted treatment, an important 
implication given the current trend of illicit drug use.  This research validates that opioid-addicted 
individuals can achieve treatment success.  Implications for this particular court are examining policies 
to retain participants with less than a high school education, such as improving literacy, and retaining 
participants with less access to prosocial support systems, such as providing more social support 
mechanisms within treatment options to further improve outcomes. 
 Drug court structure, approaches to treatment, and outcomes tend to vary widely, conditions 
that have caused concern among many researchers as to the generalizability of any drug court findings 
(Belenko, 2001; Nolan, 2001).  However, generalizability may not be achievable and studies that 
determine whether certain factors (individual or contextual) impact outcomes still contribute to the 
literature in that common procedures that are then differently applied could be implemented based on 
a larger body of research.  For example, the inclusion of a risk assessment measure or measures of 
mental health and trauma being consistently applied in drug courts overall would then influence site 
specific programming that could improve outcomes for individual drug courts that would in turn inform 
the aggregate research.  Future research should consider a more comprehensive examination of not 
only individual level factors, but also contextual level factors outside of drug court processes that could 
influence outcomes. 
  
76 
 
 
 
 
 
 
References 
 
Abbott, A. A. (2003). Meeting the challenges of substance misuse: Making inroads one step at a time. 
Health & Social Work, 28(2), 83–88.  
 
Abram, K. M., Teplin, L. A., McClelland, G. M., & Dulcan, M. K. (2003). Comorbid psychiatric disorders in 
youth in juvenile detention. Archives of General Psychiatry, 60(11), 1097. 
 
Acierno, R., Resnick, H. S., Flood, A., & Holmes, M. (2003). An acute post-rape intervention to prevent 
substance use and abuse. Addictive Behaviors, 28(9), 1701-1715. 
 
Agerwala, S. M., & McCance-Katz, E. F. (2012). Integrating screening, brief Intervention, and referral to 
treatment (SBIRT) into clinical practice settings: a brief review. .Journal of Psychoactive Drugs, 
44(4), 307-317. 
 
Agnew, R. (1992). Foundation for a general strain theory of crime and delinquency. Criminology, 30(1), 
47-87.  
 
Agnew, R. (1995). The contribution of social-psychological strain theory to the explanation of crime and 
delinquency. In F.Adler & W.S. Laufer (Series Eds.), The legacy of anomie theory: Vol. 6. 
Advances in Criminological Theory (pp. 113-137). New Brunswick, NJ: Transaction. 
 
Agnew, R. (2002). Experienced, vicarious, and anticipated strain: An exploratory study on physical 
 victimization and delinquency. Justice Quarterly, 19, 603-632. 
 
Agnew, R. (2006). General strain theory: Current status and directions for further research. In F. T. 
 Cullen, J. P. Wright, K. R. Blevins, F. T. Cullen, J. P. Wright & K. R. Blevins (Eds.), Taking stock: The 
 status of criminological theory. (pp. 101-123). New Brunswick, NJ US: Transaction Publishers. 
 
Agresti, A. (1996).An introduction to categorical data analysis (Vol. 135). New York: Wiley. 
 
Akers, R. L. (2009). Social learning and social structure: A general theory of crime and deviance. 
 Transaction Books. 
 
Allen, J. G., Coyne, L., & Huntoon, J. (1998). Complex posttraumatic stress disorder in women from a 
 psychometric perspective. Journal of Personality Assessment, 70(2), 277-298. 
 
Amaro, H., Chernoff, M., Brown, V., Arévalo, S., & Gatz, M. (2007). Does integrated trauma‐informed 
 substance abuse treatment increase treatment retention? Journal of Community 
 Psychology, 35(7), 845-862. 
 
77 
 
Andrews, D. A.& Bonta, J. (2010). The Psychology of Criminal Conduct. New Providence, NJ. Matthew 
 Bender & Company, Inc. 
Anglin, M. D., Longshore, D., & Turner, S. (1999). Treatment Alternatives to Street Crime An Evaluation 
 of Five Programs. Criminal Justice and Behavior,26(2), 168-195. 
 
Arabia, P. L., Fox, G., Caughie, J., Marlowe, D. B., & Festinger, D. S. (2008). Sanctioning practices in an 
 adult felony drug court.Drug Court Review, 6, 1-6. 
 
Apa-Hall, P., Schwartz-Bloom, R. D., & McConnell, E. S. (2008). The current state of teenage drug abuse: 
 trend toward prescription drugs. Journal of School Nursing, 24(3), S1. 
 
Asberg, K., & Renk, K. (2012). Substance use coping as a mediator of the relationship between trauma 
 symptoms and substance use consequences among incarcerated females with childhood sexual 
 abuse histories. Substance Use & Misuse, 47(7), 799-808. 
 
Banks, D., & Gottfredson, D. C. (2003). The effects of drug treatment and supervision on time to rearrest 
among drug treatment court participants. Journal of Drug Issues, 33(2), 385-412. 
 
Banks, D., & Gottfredson, D. C. (2004). Participation in drug treatment court and time to rearrest. Justice 
 Quarterly, 21(3), 637-658. 
 
Baillargeon, J., Penn, J. V., Knight, K., Harzke, A. J., Baillargeon, G., & Becker, E. A. (2010). Risk of 
reincarceration among prisoners with co-occurring severe mental illness and substance use 
disorders. Administration and Policy in Mental Health and Mental Health Services Research, 
37(4), 367-374. 
 
Baumer, E. (1994). Poverty, crack, and crime: A cross-city analysis. Journal of Research in Crime and 
 Delinquency, 31(3), 311-327. 
 
Beck, A. J. (2000). Prisoners in 1999. Washington, DC: US Department of Justice, Bureau of Justice 
 Statistics. 
 
Becker, W. C., Fiellin, D. A., & Desai, R. A. (2007). Non-medical use, abuse and dependence on sedatives 
and tranquilizers among US adults: psychiatric and socio-demographic correlates. Drug and 
Alcohol Dependence, 90(2), 280-287. 
 
Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008). Non-medical use, abuse 
 and dependence on prescription opioids among US adults: psychiatric, medical and substance 
 use correlates. Drug and Alcohol Dependence, 94(1), 38-47. 
 
Beckett, K. Nyrop, K. Pfingst,L. & Bowen, M.  (2005). Drug Use, Drug  Possession Arrests, and the 
 Question of Race: Lessons from Seattle.  Social Problems 52(3), 419-41. 
 
Beckett, K. Sasson. T. (2004).The politics of injustice: Crime and punishment in America.  Thousand Oaks, 
CA: Sage. 
 
78 
 
Belenko, S. (1998). Research on drug courts: A critical review. National Drug Court Institute Review, 1(1), 
 1-42. 
 
Belenko, S. (2006). Assessing released inmates for substance-abuse-related service needs. Crime & 
 Delinquency, 52(1), 94-113. 
 
Belenko, S. (2001). Research on drug courts: A critical review 2001 update. National Drug 
 Court Institute Review, 4, 1-60. 
 
Belenko, S. & Dumanovsky, T.,  New York City Criminal Justice Agency, Inc. (1993). Special drug courts. 
Bureau of Justice Assistance Program Brief. Washington, DC: US Department of Justice. 
 
Belenko, S., Fagan, J., & Chin, K. L. (1991). Criminal justice responses to crack. Journal of Research in 
 Crime and Delinquency, 28(1), 55-74. 
 
Belenko, S., & Peugh, J. (2005). Estimating drug treatment needs among state prison inmates. Drug and 
 Alcohol Dependence, 77(3), 269-281. 
 
Belknap, J. (2001).The invisible woman: Gender, crime, and justice (pp. 227-66). Belmont, CA: 
Wadsworth. 
 
Belknap, J. (2007). The invisible woman: Gender, crime, and justice (3rd ed.). Belmont, 
 CA: Wadsworth. 
 
Bennett, T., Holloway, K., & Farrington, D. (2008). The statistical association between drug misuse and 
 crime: A meta-analysis. Aggression and Violent Behavior, 13(2), 107-118. 
 
Bloom, B. E., Owen, B. A., & Covington, S. (2005). Gender-responsive strategies for women offenders: A 
 summary of research, practice, and guiding principles for women offenders. US Department of 
 Justice, National Institute of Corrections. 
 
Blumstein, A. (1993). Racial disproportionality of US prison populations revisited, University of Colorado 
Law Review., 64, 743. 
 
Blumstein, A., & Cohen, J. (1979). Estimation of individual crime rates from arrest records. The Journal of 
 Criminal Law and Criminology, 70(4), 561-585. 
 
Bordin, E. S.(1979). The generalizability of the psychoanalytic concept of the working alliance.  
 Psychotherapy: Theory, Research & Practice, 16(3), 252-260. 
 
Bouffard, J. A., & Richardson, K. A. (2007). The Effectiveness of Drug Court Programming for Specific 
 Kinds of Offenders Methamphetamine and DWI Offenders Versus Other Drug-Involved 
 Offenders. Criminal Justice Policy Review, 18(3), 274-293. 
 
Box, G. E. P., and D. R. Cox. 1964. An analysis of transformations. Journal of the Royal Statistical Society, 
 Series B 26: 211–252. 
 
79 
 
Bhati, A. S., & Roman, J. K. (2010). Simulated evidence on the prospects of treating more drug-involved 
offenders. Journal of Experimental Criminology, 6(1), 1-33. 
 
Brady, K. T., Back, S. E., & Greenfield, S. F. (Eds.). (2009). Women and addiction: A comprehensive 
 handbook. New York: Guilford Press. 
 
Breslau, N., Davis, G. C., & Schultz, L. R. (2003). Posttraumatic stress disorder and the incidence of 
 nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Archives of 
 General Psychiatry, 60(3), 289. 
 
Broner, N., Lattimore, P. K., Cowell, A. J., & Schlenger, W. E. (2004). Effects of diversion on adults with 
co‐occurring mental illness and substance use: outcomes from a national multi‐site study. 
Behavioral Sciences & the Law, 22(4), 519-541. 
 
Brown, R. (2010). Systematic review of the impact of adult drug-treatment courts. Translational 
 Research 155(6), 263-274. 
 
Brown, R. T., Allison, P. A., & Nieto, F. J. (2011). Impact of jail sanctions during drug court participation 
 upon substance abuse treatment completion. Addiction,106(1), 135-142. 
 
Brown, T. A., Campbell, L. A., Lehman, C. L., Grisham, J. R., & Mancill, R. B. (2001). Current and lifetime 
comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample, Journal of 
Abnormal Psychology, 110(4), 585-599. 
 
Brewster, M. P. (2001). An evaluation of the Chester County (PA) drug court program. Journal of Drug 
 Issues, 31(1), 177-206. 
 
Butzin, C. A., Saum, C. A., & Scarpitti, F. R. (2002). Factors associated with completion of a drug 
 treatment court diversion program. Substance Use & Misuse, 37(12-13), 1615-1633. 
 
Cai, R., Crane, E., Poneleit, K., & Paulozzi, L. (2010). Emergency department visits involving nonmedical 
 use of selected prescription drugs in the United States, 2004-2008. Journal of Pain and Palliative 
 Care Pharmacotherapy, 24(3), 293-297. 
 
Califano, J. A. (2005). Under the counter: The diversion and abuse of controlled prescription drugs in the 
 US. New York, NY: National Center on Addiction and Substance Abuse, Columbia University. 
Capowich, G. E., Mazerolle, P., & Piquero, A. (2001). General strain theory, situational anger, and social 
 networks: An assessment of conditioning influences. Journal of Criminal Justice, 29(5), 445-461. 
 
Carlson, B. E., Shafer, M. S., & Duffee, D. E. (2010). Traumatic histories and stressful life events of 
 incarcerated parents II: Gender and ethnic differences in substance abuse and service needs. 
 The Prison Journal, 90(4), 494-515. 
 
Caulkins, J. P., & Sevigny, E. L. (2005). How many people does the US imprison for drug use, and who are 
 they. Contemporary Drug Problems., 32, 405. 
 
80 
 
Center for Substance Abuse Treatment (CSAT). (2005). Substance abuse treatment for persons with co-
 occurring disorders. Treatment Improvement Protocol (TIP) Series. S. Sacks (Chair) & R. Reis 
 (Co-Chair), Consensus Panel. DHHS Pub.  (SMA). Rockville, MD: Substance Abuse and Mental 
 Health Services Administration. 
 
Chan, Y. F., Huang, H., Sieu, N., & Unützer, J. (2013). Substance screening and referral for substance 
 abuse treatment in an integrated mental health care program. Psychiatric Services, 64(1), 88-90. 
 
Chesney-Lind, M., Pasco, L. (2004). The Female Offender: Girls, Women, and Crime.  
 Thousand Oaks, CA: Sage Publications, Inc.  
 
Chilcoat, H. D., & Breslau, N. (1998a). Investigations of causal pathways between PTSD and drug use 
disorders. Addictive Behaviors, 23(6), 827-840. 
 
Chilcoat, H. D., & Breslau, N. (1998b). Posttraumatic stress disorder and drug disorders: testing causal 
pathways. Archives of General Psychiatry, 55(10), 913. 
 
Chong, J., & Lopez, D. (2005). Social networks, support, and psychosocial functioning among American 
 Indian women in treatment. American Indian and Alaska Native Mental Health Research, 12, 62-
 85. 
 
Cicero, T. J., Inciardi, J. A., & Muñoz, A. (2005). Trends in abuse of OxyContin® and other opioid 
 analgesics in the United States: 2002-2004. The Journal of Pain, 6(10), 662-672. 
 
Cheesman, F.L., Rubio, D. M., &  Van Dutzend, R. (2004).Developing Statewide Performance Measures 
 for Drug Courts. National Center for State Courts.  Statewide Technical Assistance Bulletin, 2, 
 1-8. 
 
Cissner, A. B., & Rempel, M. (2005). The State of Drug Court Research: Moving Beyond" do They Work?'. 
 New York: Center for Court Innovation. 
 
Clark, C., & Fearday, F. (2003). Triad women’s project: Group facilitator’s manual. University of South 
Florida. 
 
Clear, T. R., & Schrantz, D. (2011). Strategies for reducing prison populations. The Prison Journal, 91(3), 
 138S-159S. 
 
Coalition Against Insurance Fraud. (2007). Prescription for peril: how insurance fraud finances theft and 
 abuse of addictive prescription drugs.  Washington, DC: Author. 
 
Cobb, N. (2006). Patronising the mentally disordered? Social landlords and the control of ‘anti‐social 
 behaviour’under the Disability Discrimination Act 1995. Legal Studies, 26(2), 238-266. 
 
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood 
 and anxiety disorders and specific drug use disorders: results from the National Epidemiologic 
 Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67(2), 247-257. 
 
81 
 
Cosden, M., Basch, J. E., Campos, E., Greenwell, A., Barazani, S., & Walker, S. (2006). Effects of 
 motivation and problem severity on court-based drug treatment. Crime & Delinquency, 52(4), 
 599-618. 
 
Correctional Association of New York. (2006). Women in Prison Project. http://wamusa.org/pdf/WIPP-
Why-Focus-On-Incarcerated-Women-2006.pdf. 
Council, C. L. (Ed.). (2004). Health services utilization by individuals with substance abuse and  
 mental disorders (DHHS Publication No. SMA 04-3949, Analytic Series A-25). Rockville, MD:  
 Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 
 
Covington, S. (1998). The relational theory of women’s psychological development:  Implications for the 
 criminal justice system. In R. T. Zeplin (Ed.), Female offenders critical perspectives and effective 
 interventions (pp.113-128).  Gaithersburg, MD: Aspen Publishers.  
 
Cullen, F. T. (1994). Social support as an organizing concept for criminology: Presidential address to the 
 Academy of Criminal Justice Sciences. Justice Quarterly, 11(4), 527-559. 
 
Cullen, F. T. & Wright, J. P.  (1997) Liberating the anomie-strain theory paradigm: Implications from  
 social support theory. In Nikos Passas and Robert Agnew (eds.), p. 187-206. Assessing the 
 Anomie-Strain Tradition. Boston, MA: Northeastern University Press.  
 
Dakof, G. A., Cohen, J. B., Henderson, C. E., Duarte, E., Boustani, M., Blackburn, A., Hawes, S. (2010). A 
 randomized pilot study of the engaging moms program for family drug court. Journal of 
 Substance Abuse Treatment, 38(3), 263-274. 
 
Daly, K. (1994). Gender, crime, and punishment. Yale University Press. 
 
Daniel, A. E. (2007). Care of the mentally ill in prisons: challenges and solutions. Journal of the American 
 Academy of Psychiatry and the Law Online, 35(4), 406-410. 
 
Dannerbeck, A., Harris, G., Sundet, P., & Lloyd, K. (2006). Understanding and responding to racial 
 differences in drug court outcomes. Journal of Ethnicity in Substance Abuse, 5(2), 1–22. 
 
Dass-Brailsford, P., & Myrick, A. C. (2010). Psychological trauma and substance abuse: The need for an 
 integrated approach. Trauma, Violence, & Abuse, 11(4), 202-213. 
 
Davis, M. I., & Jason, L. A. (2005). Sex differences in social support and self-efficacy within a recovery 
 community. American Journal of Community Psychology, 36(3-4), 259-274. 
 
Deschenes, E. P., Ireland, C., & Kleinpeter, C. B. (2009). Enhancing drug court success. Journal of 
 Offender Rehabilitation, 48(1), 19-36. 
 
DeMatteo, D., Marlowe, D. B., Festinger, D. S., & Arabia, P. L. (2009). Outcome Trajectories in Drug Court 
 Do All Participants Have Serious Drug Problems?. Criminal Justice and Behavior, 36(4), 354-368. 
 
82 
 
Dennis, M. L., White, M. K., Titus, J. C., & Unsicker, J. I. (2006). Short Blessed Scale Exam: Global 
 Appraisal of Individual Needs: Trainer’s Training Manual and Resources. July 2006 version. 
 Bloomington, IL: Chestnut Health Systems. 
 
Derogatis, L. R., & Spencer, M. S. (1982). The Brief Symptom Inventory (BSI): Administration, scoring, 
 and procedures manual-1. Baltimore: Johns Hopkins University School of Medicine, Clinical 
 Psychometrics Research Unit 
 
Ditton, P. M. (1999). Special Report Mental Health and Treatment of Inmates and Probationers. 
 Washington, DC: US Department of Justice, Bureau of Justice Statistics. 
 
Dobkin, P. L., Civita, M. D., Paraherakis, A., & Gill, K. (2002). The role of functional social support in 
 treatment retention and outcomes among outpatient adult substance abusers. Addiction, 97(3), 
 347-356. 
 
Dowden, C., & Andrews, D. A. (1999). What works for female offenders: A meta-analytic review. Crime & 
 Delinquency, 45(4), 438-452. 
 
Dowden, C., & Brown, S. L. (2002). The role of substance abuse factors in predicting recidivism: A meta-
 analysis. Psychology, Crime and Law, 8(3), 243-264. 
 
Draine, J., & Herman, D. (2007). Critical time intervention for reentry from prison for persons with 
 mental illness. Psychiatric Services, 58(12), 1577-1581. 
 
Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004). A review of treatments for people 
 with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation 
 Journal, 27(4), 360. 
 
Drug Enforcement Administration (2001)., Last Acts, Pain and Policy Studies Group, American Academy 
 of Hospice and Palliative Medicine, American Academy of Pain Medicine, American Alliance of 
 Cancer Pain Initiatives. Promoting pain relief and preventing abuse of pain medications: A 
 critical balancing act. Washington, DC: Last Acts, 2001. Available at 
 www.medsch.wisc.edu/painpolicy/dea01.htm. 
 
Durlauf, S. N., & Nagin, D. S. (2011). Imprisonment and crime. Criminology & Public Policy, 10(1), 13-54. 
 
Dynia, P., & Sung, H. E. (2000). The safety and effectiveness of diverting felony drug offenders to 
 residential treatment as measured by recidivism. Criminal Justice Policy Review, 11(4), 299-311. 
 
El-Bassel, N., Chen, D. R., & Cooper, D. (1998). Social support and social network profiles among women 
 on methadone. Social Service Review, 72(3), 379-491. 
 
Evans, E., Li, L., & Hser, Y. I. (2009). Client and program factors associated with dropout from court 
 mandated drug treatment. Evaluation and Program Planning, 32(3), 204-212. 
 
83 
 
Fallot, R. D., & Harris, M. (2002). The Trauma Recovery and Empowerment Model (TREM): Conceptual 
and practical issues in a group intervention for women. Community Mental Health Journal, 
38(6), 475-485. 
 
Fazel, S., & Danesh, J. (2002). Serious mental disorder in 23,000 prisoners: a systematic review of 62 
 surveys. The Lancet, 359(9306), 545-550. 
 
Festinger, D. S., Marlowe, D. B., Lee, P. A., Kirby, K. C., Bovasso, G., & McLellan, A. T. (2002). Status 
 hearings in drug court: When more is less and less is more. Drug and Alcohol Dependence, 68(2), 
 151-157. 
 
Finigan, M. W. (2009). Understanding racial disparities in drug courts. Drug Court Review, 6(2), 135-142 
 
Finn, P., & Newlyn, A. K. (1997). Miami’s drug court: A different approach. In L. K. Gaines & P. 
 B. Kraska (Eds.), Drugs, crime, and justice(pp. 357-374). Prospect Heights, IL: Waveland. 
 
Ford, J. D., Courtois, C. A., Steele, K., Hart, O. V. D., & Nijenhuis, E. R. (2005). Treatment of complex 
 posttraumatic self‐dysregulation. Journal of Traumatic Stress, 18(5), 437-447. 
 
Ford, J. D., Hawke, J., Alessi, S., Ledgerwood, D., & Petry, N. (2007). Psychological trauma and PTSD 
 symptoms as predictors of substance dependence treatment outcomes. Behaviour Research and 
 Therapy, 45(10), 2417-2431. 
 
Ford, J. A., & Schroeder, R. D. (2008). Academic strain and non-medical use of prescription stimulants 
 among college students. Deviant Behavior, 30(1), 26-53. 
 
Fradella, H. F., Fischer, R. G., Kleinpeter, C. H., & Koob, J. J. (2009). Latino Youth in the Juvenile Drug 
 Court of Orange County, California. Journal of Ethnicity in Criminal Justice, 7(4), 271-292. 
 
Frisher, M., Crome, I., Macleod, J., Millson, D., & Croft, P. (2005). Substance misuse and psychiatric 
 illness: prospective observational study using the general practice research database. Journal of 
 Epidemiology and Community Health, 59 (10), 847-850. 
 
Gallagher, J. R. (2013) Drug Court Graduation Rates: Implications for Policy Advocacy and Future 
 Research, Alcoholism Treatment Quarterly, 31:2, 241-253 
 
Garland, D. (2001). The culture of control: Crime and social order in contemporary society (Vol. 77). 
 Oxford: Oxford University Press. 
 
Garrity, A.G., Pearlson, G.D., McKiernan, K., Lloyd, D., Kiehl, K.A., Calhoun, V.D., 2007. Aberrant “default 
 mode” functional connectivity in schizophrenia. American Journal of Psychiatry, 164, 450–457 
 
Garrity, T.F.,Prewitt, S.H., Joosen, M., Staton Tindall, M., Webster, J.M., Hiller, M.L., & Leukefeld, C.G. 
 (2006). Correlates of subjective stress among drug court clients. International Journal of 
 Offender Therapy and Comparative Criminology, 50(3), 269-279. 
 
84 
 
Gearon, J. S., Nidecker, M., Bellack, A., & Bennett, M. (2003). Gender differences in drug use behavior in 
 people with serious mental illnesses. The American Journal on Addictions, 12(3), 229-241. 
 
Gibbs, L. S., & Haddox, J. D. (2003). Lawful prescribing and the prevention of diversion. Journal of Pain 
 and Palliative Care Pharmacotherapy, 17(1), 5-14. 
 
Gil-Rivas, V., Prause, J., & Grella, C. E. (2009). Substance use after residential treatment among 
 individuals with co-occurring disorders: the role of anxiety/depressive symptoms and trauma 
 exposure. Psychology of Addictive Behaviors, 23(2), 303. 
 
Goldkamp, J. S., White, M. D., & Robinson, J. B. (2001). Do drug courts work? Getting inside the drug 
 court black box. Journal of Drug Issues, 31(1), 27-72. 
 
Goldstein, Paul J. 1985. The drugs/violence nexus: A tripartite conceptual framework. Journal of Drug 
 Issues 15:493–506. 
 
Goode, E. (2002). Drug arrests at the millennium. Society, 39(5), 41-45. 
 
Gottfredson, D. C., & Exum, M. L. (2002). The Baltimore city drug treatment court: One-year results from 
 a randomized study.Journal of Research in Crime and Delinquency, 39(3), 337-356. 
 
Gottfredson, D. C., Kearley, B. W., Najaka, S. S., & Rocha, C. M. (2007). How Drug Treatment Courts 
 Work An Analysis of Mediators. Journal of Research in Crime and Delinquency, 44(1), 3-35. 
 
Gottfredson, D. C., Najaka, S. S., & Kearley, B. (2003). Effectiveness of Drug Treatment Courts: Evidence 
 From A Randomized Trial*.Criminology & Public Policy, 2(2), 171-196. 
 
Government Accountability Office. (2011).  Adult Drug Courts - Highlights of GAO-12-53, a report to  
 congressional committees.  
 
Gray, A., & Saum, C. A. (2005). Mental health, gender, and drug court completion. American Journal of 
 Criminal Justice, 30(1), 55-69. 
 
Green, B. L., Miranda, J., Daroowalla, A., & Siddique, J. (2005). Trauma exposure, mental health 
 functioning, and program needs of women in jail. Crime & Delinquency, 51(1), 133-151. 
 
Hagedorn, H., & Willenbring, M. L. (2003). Psychiatric illness among drug court probationers. The 
 American Journal of Drug and Alcohol Abuse, 29(4), 775-788. 
 
Hansen, R. N., Oster, G., Edelsberg, J., Woody, G. E., & Sullivan, S. D. (2011). Economic costs of 
 nonmedical use of prescription opioids. The Clinical Journal of Pain, 27(3), 194-202. 
 
Hartley, R. E., & Phillips, R. C. (2001). Who graduates from drug courts? Correlates of client 
 success. American Journal of Criminal Justice, 26(1), 107-119. 
 
85 
 
Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992). Risk and protective factors for alcohol and other 
 drug problems in adolescence and early adulthood: implications for substance abuse 
 prevention. Psychological Bulletin, 112(1), 64. 
 
Harwood, H. J., Hubbard, R. L., Collins, J. J., & Rachal, J. V. (1988). The costs of crime and the benefits of 
drug abuse treatment: A cost-benefit analysis using TOPS data. NIDA Research Monograph, 86, 
209-235. 
 
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive 
 disorder: results from the National Epidemiologic Survey on Alcoholism and Related 
 Conditions. Archives of General Psychiatry, 62(10), 1097. 
 
Havassy, B. E., Hall, S. M., & Wasserman, D. A. (1991). Social support and relapse: Commonalities among 
 alcoholics, opiate users, and cigarette smokers. Addictive Behaviors, 16(5), 235-246. 
 
Hearn, W. L., Rose, S., Wagner, J., Ciarleglio, A., & Mash, D. C. (1991). Cocaethylene is more potent than 
 cocaine in mediating lethality. Pharmacology Biochemistry and Behavior, 39(2), 531-533. 
 
Heimer, Karen. 2000. Changes in the gender gap in crime and women’s economic marginalization. In The 
 Nature of Crime: Continuity and Change; Criminal Justice 2000, vol. 1, ed. Gary LaFree. 
 Washington, DC: National Institute of Justice. 
 
Hein, D.A., Nunes, E., Levin, F.R., & Fraser,  D. (2000) Posttraumatic stress disorder and short-term 
outcome in early methadone treatment. Journal of Substance Abuse Treatment, 19, 31–7. 
 
Hein, D., Zimberg, S., Weisman, S., First, M. & Ackerman, S. (1997). Dual diagnosis subtypes in urban 
 substance abuse and mental health clinics. Journal of Psychiatric Services, 48, 1058-1063. 
 
Henwood, B., & Padgett, D. K. (2007). Reevaluating the Self‐Medication Hypothesis among the Dually 
 Diagnosed. The American Journal on Addictions,16(3), 160-165. 
 
Hepburn, J. R., & Harvey, A. N. (2007). The effect of the threat of legal sanction on program retention 
 and completion: Is that why they stay in drug court?. Crime & Delinquency, 53(2), 255-280. 
 
Herman-Stahl, M. A., Krebs, C. P., Kroutil, L. A., & Heller, D. C. (2007). Risk and protective factors for  
 methamphetamine use and nonmedical use of prescription stimulants among young adults aged 
 18 to 25.Addictive Behaviors, 32(5), 1003-1015. 
 
Hernandez, S. H., & Nelson, L. S. (2010). Prescription drug abuse: insight into the epidemic. Clinical 
 Pharmacology & Therapeutics, 88(3), 307-317. 
 
Hickert,A.O., Boyle, S.W., Tollefson, D.R., (2009). Factors that predict drug court completion and 
 dropout: Findings from an evaluation of Salt Lake County’s adult felony drug court. Journal of 
 Social Service Research, 35, 149-162. 
 
Hiller, M. L., Knight, K., & Simpson, D. D. (1999). Risk factors that predict dropout from corrections-based 
 treatment for drug abuse. The Prison Journal, 79(4), 411-430. 
86 
 
 
Hirschi, T., & Gottfredson, M. (1983). Age and the explanation of crime. American Journal of Sociology, 
 552-584. 
 
Hoffman, M. B. (1999). Drug Court Scandal, The NCL Review, 78, 1437. 
 
Hosmer Jr, D. W.,&  Lemeshow, S. (2010).Applied logistic regression. John Wiley & Sons; New York. 
 
Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W., Saha, T. D., ... & Grant, B. F. (2006). 
 Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use 
 disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and 
 Related Conditions. Journal of Clinical Psychiatry, 67(7), 1062-1073. 
 
Hubbard, D. J., & Matthews, B. (2008). Reconciling the differences between the “gender-responsive” 
 and the “what works” literatures to improve services for girls. Crime & Delinquency, 54(2), 225-
 258. 
Huddleston, C. W., & Marlowe, D. B. (2011). Painting the current picture: A national report on drug 
 courts and other problem-solving court programs in the United States. Washington, DC: National 
 Drug Court Institute. 
 
Huddleston, C. West, Douglas Marlowe, and Rachel Casebolt. 2008. Painting the current picture: A 
 National Report Card on Drug Courts and other problem-solving court programs in the United 
 States. Washington, DC: Bureau of Justice Assistance, Office of Justice Programs, US Department 
 of Justice. 
 
Huebner, B. M., & Bynum, T. S. (2008). The role of race and ethnicity in parole  decisions*. Criminology, 
46(4), 907-938. 
 
Hyer, L., Davis, H., Boudewyns, P., & Woods, M. G. (1991). A short form of the Mississippi scale for 
 Combat‐Related PTSD. Journal of Clinical Psychology, 47(4), 510-518. 
 
Incardi, J. A., McBride, D. C., & McCoy, H. V. (1997). Recent research on the crack/cocaine/crime 
 connection. Drug Use and Drug Policy, 2, 133. 
 
Jacobsen, L.K., Southwick, S.M., Kosten, T. R. (2001). Substance Use Disorders in Patients with 
 Posttraumatic Stress Disorder: A Review of the Literature. American Journal of Psychiatry 
 158, 1184–1190 
 
James, D. J., & Glaze, L. E. (2006). Mental health problems of prison and jail inmates. Washington, DC: US 
 Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. 
 
Johnson, J. G., Cohen, P., Brown, J., Smailes, E. M., & Bernstein, D. P. (1999). Childhood maltreatment 
 increases risk for personality disorders during early adulthood. Archives of General 
 Psychiatry, 56(7), 600. 
 
87 
 
Johnson, R. J., Ross, M. W., Taylor, W. C., Williams, M. L., Carvajal, R. I., & Peters, R. J. (2006). Prevalence 
 of childhood sexual abuse among incarcerated males in county jail. Child Abuse & Neglect, 30(1), 
 75-86. 
 
Johnston, L.D., O’Malley, P.M., Bachman, J. G., & Schulenberg, J. E. (2012). Monitoring the future 
national results on adolescent drug use: overview of key findings, 2011. Ann Arbor (MI): Institute 
for Social Research, The University of Michigan. 
 
Keane, T. M., Caddell, J. M., & Taylor, K. L. (1988). Mississippi Scale for Combat-Related Posttraumatic 
 Stress Disorder: Three studies in reliability and validity. Journal of Consulting and Clinical 
 Psychology, 56(1), 85. 
 
Kessler, R. C., Berglund, P., Borges, G., Nock, M., & Wang, P. S. (2005). Trends in suicide ideation, plans, 
 gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA: The Journal of the 
 American Medical Association, 293(20), 2487-2495. 
 
Khantzian, E. J., & Treece, C. (1985). DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. 
 Archives of General Psychiatry, 42(11), 1067. 
 
Khoury, L., Tang, Y. L., Bradley, B., Cubells, J. F., & Ressler, K. J. (2010). Substance use, childhood 
traumatic experience, and posttraumatic stress disorder in an urban civilian population. 
Depression and Anxiety, 27(12), 1077-1086. 
 
Kim, M., & Hill, R. C. (1993). The Box-Cox transformation-of-variables in regression. Empirical 
 Economics, 18(2), 307-319. 
 
King, R. S. The Sentencing Project (2008) Disparity by geography The War on Drugs in America’s cities. 
 project report. http://www.opensocietyfoundations.org/reports/disparity-geography  
 
King, R., & Pasquarella, J. (2009). Drug courts a review of the evidence.
 http://www.sentencingproject.org/doc/dp_drugcourts.pdf 
 
King, D. W., King, L. A., Fairbank, J. A., Schlenger, W. E., & Surface, C. R. (1993). Enhancing the precision 
 of the Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: An application of 
 item response theory. Psychological Assessment, 5(4), 457. 
 
Kingston, S., & Raghavan, C. (2009). The relationship of sexual abuse, early initiation of substance use, 
 and adolescent trauma to PTSD. Journal of Traumatic Stress, 22(1), 65-68. 
 
Krohn, M. D., Lizotte, A. J., Thomberry, T. P., Smith, C., & McDowall, D. (1996). Reciprocal causal 
 relationships among drug use, peers, and beliefs: A five-wave panel model. Journal of Drug 
 Issues, 26, 405-429. 
 
Lamb, H. R., & Weinberger, L. E. (2005). The shift of psychiatric inpatient care from hospitals to jails and 
 prisons. Journal of the American Academy of Psychiatry and the Law Online, 33(4), 529-534. 
 
88 
 
Langan, P. A., & Levin, D. J. (2002). Recidivism of prisoners released in 1994.Federal Sentencing 
 Reporter, 15(1), 58-65. 
 
Laudet, A. B., Magura, S., Vogel, H. S., & Knight, E. L. (2004). Perceived reasons for substance misuse 
 among persons with a psychiatric disorder. American Journal of Orthopsychiatry, 74(3), 365-375. 
 
Lauritsen, J. L., Heimer, K., & Lynch, J. P. (2009). Trends in the gender gap in violent offending: new 
 evidence from the national crime victimization survey*.Criminology, 47(2), 361-399. 
 
Lauterbach, D., Vrana, S., King, D. W., & King, L. A. (1997). Psychometric properties of the civilian version 
 of the Mississippi PTSD Scale. Journal of Traumatic Stress, 10(3), 499-513. 
 
Law, M. (2005). „Reduce, Reuse, Recycle: Issues in the Secondary Use of Research Data. IASSIST 
 Quarterly, 29(1), 5-10. 
 
Lesperance, T., Moore, K. A., Barrett, B., Young, M. S., Clark, C., & Ochshorn, E. (2011). Relationship 
 between trauma and risky behavior in substance-abusing parents involved in a Family 
 Dependency Treatment Court. Journal of Aggression, Maltreatment & Trauma, 20(2), 163-174. 
 
Leverentz, A. M. (2006). The love of a good man? Romantic relationships as a source of support or 
 hindrance for female ex-offenders. Journal of Research in Crime and Delinquency, 43(4), 459-
 488. 
 
Levinthal, C. F. (2008). Drugs, society, and criminal justice. Pearson/Allyn and Bacon. 
 
Lindsey, C., & Sheather, S. J. (2010). Optimal power transformation via inverse response plots. Stata 
 Journal, 10(2), 200-214. 
 
Lo, S. K., Li, I. T., Tsou, T. S., & See, L. (1995). Non-significant in univariate but significant in multivariate 
analysis: a discussion with examples.Changgeng yi xue za zhi/Changgeng ji nian yi yuan= Chang 
Gung medical journal/Chang Gung Memorial Hospital,18(2), 95-101. 
 
Loeber, R., Farrington, D., Stouthamer-Loeber, M., Moffitt, T. E., & Caspi, A. (1998). The development of 
 male offending: Key findings from the first decade of the Pittsburgh Youth Study. Studies on 
 Crime and Crime Prevention, 7, 141-172. 
 
Logan, T. K., Williams, K., Leukefeld, C., & Minton, L. (2000). A drug court process evaluation: 
 Methodology and findings. International Journal of Offender Therapy and Comparative 
 Criminology, 369-394. 
 
Lowenkamp, C., Holsinger, A. M., & Latessa, E. J. (2005). Are drug courts effective: A meta-analytic 
 review. Journal of Community Corrections, 28, 5-10. 
 
Lutze, F. E., & van Wormer, J. G. (2007). Criminal Justice Policy. Policy Review, 18(3), 226-245. 
 
MacCoun, R., Kilmer, B., & Reuter, P. (2003). Research on drugs-crime linkages: The next 
 generation. Toward a drugs and crime research agenda for the 21st century, 65-95. 
89 
 
 
MacKenzie, D. L., & Uchida, C. D. (Eds.). (1994). Drugs and crime: Evaluating public policy initiatives. 
 Thousand Oaks, CA: Sage. 
 
Maguire, L. (1991) Social Support Systems in Practice: A Generalist Approach. Washington, D.C.: National 
 Association of Social Workers (NASW) Press. 
 
Maremmani, I., Pacini, M., & Lovrecic, M. (2004). Clinical foundations for the use of methadone in jail. 
 Heroin Addiction and Related Clinical Problems, 6, 53-72. 
 
Marlowe, D. B. (2010). Research update on adult drug courts.
 http://www1.spa.american.edu/justice/documents/3067.pdf 
 
Marlowe, D. B., Festinger, D. S., Lee, P. A., Dugosh, K. L., & Benasutti, K. M. (2006). Matching judicial 
 supervision to clients’ risk status in drug court. Crime & Delinquency, 52(1), 52-76. 
 
Martin, S. S., Butzin, C. A., Saum, C. A., & Inciardi, J. A. (1999). Three-year outcomes of therapeutic 
 community treatment for drug-involved offenders in Delaware: From prison to work release to 
 aftercare. The Prison Journal, 79(3), 294-320. 
 
Martinson, R. (1974). "What Works? - Questions and Answers About Prison Reform,"The Public Interest, 
 pp. 22-54. 
 
Mauer, M. (2003). Comparative International Rates of Incarceration: An Examination of Causes and 
 Trends Presented to the US Commission on Civil Rights. Washington, DC: The Sentencing 
Project. 
 
Mauer, M., & King, R. S. (2007a). Uneven justice: State rates of incarceration by race and ethnicity (pp. 1-
 23). Washington, DC: The Sentencing Project. 
 
Mauer, M., & King, R. S. (2007b). A 25-year quagmire: The war on drugs and its impact on American 
 society. Washington, DC: The Sentencing Project. 
 
McCabe, S. E., Cranford, J. A., Morales, M., & Young, A. (2006). Simultaneous and concurrent polydrug 
 use of alcohol and prescription drugs: prevalence, correlates, and consequences. Journal of 
 Studies on Alcohol, 67(4), 529. 
 
McCabe, S. E., Teter, C. J., Boyd, C. J., Knight, J. R., & Wechsler, H. (2005). Nonmedical use of prescription 
 opioids among US college students: Prevalence and correlates from a national survey. Addictive 
 Behaviors, 30(4), 789-805. 
 
McCauley, J., Ruggiero, K. J., Resnick, H. S., Conoscenti, L. M., & Kilpatrick, D. G. (2009). Forcible, drug-
 facilitated, and incapacitated rape in relation to substance use problems: Results from a national 
 sample of college women. Addictive Behaviors, 34(5), 458-462. 
 
McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., & O'Brlen, C. P. (1993). The effects of 
 psychosocial services in substance abuse treatment. Journal of Addictions Nursing, 5(2), 38-47. 
90 
 
 
Merrall, E. L., & Bird, S. M. (2009). A statistical perspective on the design of drug-court  studies. 
Evaluation Review, 33(3), 257-280. 
 
Menard, S. (1995). Applied logistic regression analysis: Sage university series on quantitative 
 applications in the social sciences.  Thousand Oaks, CA: Sage. 
 
Menard, S. (2011). Standards for standardized logistic regression coefficients. Social Forces, 89(4), 1409-
 1428. 
 
Mendoza, N. S., Trinidad, J. R., Nochajski, T. H., & Farrell, M. C. (2013). Symptoms of depression and 
 successful drug court completion. Community Mental Health Journal, 49, 787-792. 
 
Messina, N., Grella, C. E., Cartier, J., & Torres, S. (2010). A randomized experimental study of gender-
 responsive substance abuse treatment for women in prison. Journal of Substance Abuse 
 Treatment, 38(2), 97-107. 
 
Miethe, T. D., Lu, H., & Reese, E. (2000). Reintegrative shaming and recidivism risks in drug court: 
 Explanations for some unexpected findings. Crime & Delinquency, 46(4), 522-541. 
 
Miller, M. (2004). Sentencing Reform Reform: The Sentencing Information System Alternative to 
 Sentencing Guidelines. 
 
Miller, D., & Guidry, L. (2001).Addictions and trauma recovery: Healing the body, mind and spirit. New 
York: WW Norton & Co. 
 
Miller, N. A., & Najavits, L. M. (2012). Creating trauma-informed correctional care: a balance of goals and 
 environment. European Journal of Psychotraumatology, 3. 
 
Miller, J. M., & Shutt, J. E. (2001). Considering the need for empirically grounded drug court screening 
 mechanisms. Journal of Drug Issues, 31(1), 91-106. 
 
Minkoff, K. (2008). Dual diagnosis enhanced programs. Journal of Dual Diagnosis, 4(3), 320-325. 
 
Mitchell, O., Wilson, D. B., Eggers, A., & MacKenzie, D. L. (2012). Assessing the effectiveness of drug 
 courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. 
 Journal of Criminal Justice, 40, 60-71. 
 
Modisette, K. C., Hunter, B. D., Ives, M. L., Funk, R. R., & Dennis, M. L. (2009). NORMS including alpha, 
 mean, N, sd, ICC for adolescents (by demographics) and overall for young adults (18–25) and 
 adults (18+) using the CLAT 2008 V5 Dataset. Chestnut Health Systems. 
 
Moffitt, T. E. (1993). Adolescence-limited and life-course-persistent antisocial behavior: a developmental 
 taxonomy. Psychological Review, 100 (4), 674. 
 
Moffitt, T. E. (1994). Natural histories of delinquency. In Cross-national longitudinal research on human 
 development and criminal behavior(pp. 3-61). Springer Netherlands. 
91 
 
 
Moffitt, T. E., & Caspi, A. (2001). Childhood predictors differentiate life-course persistent and 
 adolescence-limited antisocial pathways among males and females. Development and 
 Psychopathology, 13(2), 355-375. 
 
Morash, M. (2006). Understanding gender, crime, and justice. Thousand Oaks, CA: Sage Publications. 
 
Mosher, C. (2001). Predicting drug arrest rates: Conflict and social disorganization perspectives. Crime & 
 Delinquency, 47(1), 84-104. 
 
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. 
 Addictive Behaviors, 23(6), 717-734. 
 
Mundry, R., & Nunn, C. L. (2009). Stepwise model fitting and statistical inference: turning noise into 
 signal pollution.The American Naturalist, 173(1), 119-123. 
 
Najavits, L. M. (2006). Present-versus past-focused therapy for posttraumatic stress disorder/substance 
 abuse: A study of clinician preferences. Brief Treatment and Crisis Intervention, 6 (3), 248. 
 
National Association of Drug Court Professionals. (2011). Drug court history. 
 http://www.nadcp.org/learn/what-are-drug-courts/history 
 
National Drug Control Strategy. (2011)  Office of National Drug Control Policy.  
 
National Drug Intelligence Center, U.S. Department of Justice. National Drug Threat Assessment, 2011.  
 Product No . 2011-Q0317-001 
 
National Institutes of Health, National Institute on Drug Abuse, & United States of America. (2007). 
 Drugs, Brains, and Behavior: The Science of Addiction. 
 
National Institute of Justice. (2006).  Drug Courts: The Second Decade. U.S. Department of Justice, Office 
 of Justice Programs. 
 
Najavits, L. M. (2002). Seeking Safety: A treatment manual for PTSD and substance abuse.  New York: 
Guilford Press. 
 
Najavits, L. M. (2004). Assessment of trauma, PTSD, and substance use disorder. In John P. Wilson 7 
Terence M. Keane (Eds.) Assessing psychological trauma and PTSD, 466-491. 
 
Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1999). A clinical profile of women with posttraumatic stress 
 disorder and substance dependence. Psychology of Addictive Behaviors, 13(2), 98. 
 
Nester, E.J. & Malenka, R. C (2004). The Addicted Brain. Scientific American, 78-85. 
 
Nocon, A., Berge, D., Astals, M., Martin-Santos, R., & Torrens, M. (2007). Dual diagnosis in an inpatient 
 drug-abuse detoxification unit. European Addiction Research, 13(4), 192-200. 
 
92 
 
Nolan Jr, J. L. (2010). Harm Reduction and the American Difference: Drug Treatment and Problem-
 Solving Courts in Comparative Perspective. Journal of Health Care Law & Policy, 13, 31. 
 
O’Brien, C. P. (2005). Anticraving medications for relapse prevention: a possible new class of 
 psychoactive medications. American Journal of Psychiatry, 162(8), 1423-1431. 
 
Ouimette, P. C., Finney, J. W., & Moos, R. H. (1999). Two-year posttreatment functioning and coping of 
 substance abuse patients with posttraumatic stress disorder. Psychology of Addictive 
 Behaviors, 13(2), 105. 
 
Ouimette, P. C., Brown, P. J., & Najavits, L. M. (1998). Course and treatment of patients with both 
 substance use and posttraumatic stress disorders. Addictive Behaviors, 23(6), 785-795. 
 
Palmer, E. J., & Hollin, C. R. (2007). The Level of Service Inventory-Revised with English women 
 prisoners: A needs and reconviction analysis. Criminal Justice and Behavior, 34(8), 971-984. 
 
Paulozzi, L. J., Weisler, R. H., & Patkar, A. A. (2011). A national epidemic of unintentional prescription 
 opioid overdose deaths: how physicians can help control it. Journal of Clinical Psychiatry, 72(5), 
 589. 
 
Peters, R. H., Haas, A. L., & Murrin, M. R. (1999). Predictors of retention and arrest in drug courts. 
National Drug Court Institute Review, 2(1), 33-60. 
 
Petersen, C. L., & Zettle, R. D. (2010). Treating inpatients with comorbid depression and alcohol use 
 disorders: A comparison of acceptance and commitment therapy versus treatment as usual. The 
 Psychological Record, 59(4), 2. 
 
Peyton, E. A., & Gossweiler, R. (2001). Treatment services in adult drug courts: Report on the 1999 
National Drug Court Treatment Survey [executive summary].Washington, DC: US Department of 
Justice. 
 
Picken, A., & Tarrier, N. (2011). Trauma and comorbid posttraumatic stress disorder in individuals with 
 schizophrenia and substance abuse. Comprehensive Psychiatry, 52(5), 490-497. 
 
Piquero, A. R., Farrington, D. P., & Blumstein, A. (2003). The criminal career paradigm. Crime and Justice, 
 30, 359-506. 
 
Piquero, N. L., & Sealock, M. D. (2004). Gender and general strain theory: A preliminary test of Broidy 
 and Agnew's Gender/GST hypothesis. JQ: Justice Quarterly, 21(1), 125-158. 
 
Press, S. J., & Wilson, S. (1978). Choosing between logistic regression and discriminant analysis. Journal 
 of the American Statistical Association, 73(364), 699-705. 
 
Quintero, G., Peterson, J., & Young, B. (2006). An exploratory study of socio-cultural factors contributing 
 to prescription drug misuse among college students. Journal of Drug Issues, 36(4), 903-931. 
 
93 
 
Ramlow, B. E., White, A. L., Watson, D. D., & Leukefeld, C. G. (1997). The needs of women with 
 substance use problems: An expanded vision for treatment. Substance Use & Misuse, 32(10), 
 1395-1404. 
 
Rawson, R.; Shoptaw, S.J.; Obert, J.L.; McCann, M.J.; Hasson, A.L.; Marinelli-Casey, P.J.; Brethen, P.R.; 
and Ling, W. (1995). An intensive outpatient approach for cocaine abuse: The Matrix model. 
Journal of Substance Abuse Treatment, 12(2):117-127. 
 
Rawson, R.A.; Huber, A.; McCann, M.; Shoptaw, S.; Farabee, D.; Reiber, C.; and Ling, W.  (2002). A 
comparison of contingency management and cognitive-behavioral approaches during 
methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry 
59(9):817-824, 2002. 
 
Reinarman, C., & Levine, H. G. (Eds.). (1997).Crack in America: Demon drugs and social justice. 
 Berkeley and Los Angeles (CA): University of California Press. 
 
Rempel, M., & Destefano, C. D. (2002). Predictors of engagement in court-mandated treatment: Findings 
 at the Brooklyn Treatment Court, 1996-2000. Journal of Offender Rehabilitation, 33(4), 87-124. 
 
Rempel, M., Green, M., & Kralstein, D. (2012). The impact of adult drug courts on crime and 
 incarceration: findings from a multi-site quasi-experimental design. Journal of Experimental 
 Criminology, 8(2), 165-192. 
 
Riani, M., and A. C. Atkinson. 2000. Robust diagnostic data analysis: Transformations in regression. 
 Technometrics, 42, 384–394. 
 
Roll, J. M., Prendergast, M., Richardson, K., Burdon, W., & Ramirez, A. (2005).  Identifying predictors of 
 treatment outcome in a drug court program. American Journal of Drug and Alcohol Abuse, 31(4), 
 641-656. 
 
Roman, J., Townsend, W., & Bhati, A. S. (2003). Recidivism rates For drug court graduates: Nationally 
 based estimates.  Washington, DC: U.S. Department of Justice. 
 
Rosenberg, J., Mark, S., & No, P. B. (2011). Balanced Justice: Policy brief 11.  New York: Institute for 
Policy Integrity: New York University School of Law 
 
Roskes, E., & Feldman, R. (1999). A collaborative community-based treatment program for offenders 
 with mental illness. Psychiatric Services, 50(12), 1614-1619. 
 
Rossman, S., Roman, J., Zweig, J., Rempel, M., & Lindquist, C. (2011). The multi-site adult drug court 
 evaluation: Executive summary. http://www.urban.org/UploadedPDF/412353-multi-site-adult-
 drug-court.pdf 
 
Sacks, S., Banks, S., McKendrick, K., & Sacks, J. Y. (2008). Modified therapeutic community for co-
 occurring disorders: A summary of four studies. Journal of Substance Abuse Treatment, 34(1), 
 112-122. 
 
94 
 
Sampson, R. J., & Laub, J. (1993). Crime in the Making: Pathways and Turning Points through Life. 
 Cambridge, MA: Harvard University Press. 
 
Sampson, R. J., & Laub, J. (2003).  Life-Course Desisters? Trajectories of Crime among Delinquent Boys 
 Followed to Age 70.  Criminology, 41 (3), 301-340. 
 
Sanford, J. S., & Arrigo, B. A. (2005). Lifting the cover on drug courts: Evaluation findings and policy 
concerns. International Journal of Offender Therapy and Comparative Criminology, 49(3), 239-
259. 
 
Sarchiapone, M., Carli, V., Cuomo, C., Marchetti, M., & Roy, A. (2009). Association between childhood 
 trauma and aggression in male prisoners. Psychiatry Research, 165(1), 187-192. 
 
Saum, C. A., Scarpitti, F. R., & Robbins, C. A. (2001). Violent offenders in drug court. Journal of Drug 
 Issues, 31(1), 107-128. 
 
Schäfer, I., & Najavits, L. M. (2007). Clinical challenges in the treatment of patients with posttraumatic 
 stress disorder and substance abuse. Current Opinion in Psychiatry, 20(6), 614-618. 
 
Schaeffer, C. M., Henggeler, S. W., Chapman, J. E., Halliday-Boykins, C. A., Cunningham, P. B., Randall, J., 
 & Shapiro, S. B. (2010). Mechanisms of effectiveness in juvenile drug court: Altering risk 
 processes associated with delinquency and substance abuse. Drug Court Review, 7(1), 57-94. 
 
Shaffer, D. K. (2011). Looking Inside the Black Box of Drug Courts: A Meta‐Analytic Review. Justice 
 Quarterly, 28(3), 493-521. 
 
Schiff, M. & Terry, W.C. (1997). Predicting graduation from Broward County’s dedicated drug treatment 
 court. The Justice System Journal, 19(3), 291-310. 
 
Schroeder, R. D., Giordano, P. C., & Cernkovich, S. A. (2007). Drug use and desistance processes. 
Criminology, 45(1), 191-222. 
 
Sechrest, D.K. & Shichor, D. (2001). Determinates of graduation from a day treatment drug court in 
 California: A preliminary study. Journal of Drug Issues, 31(1), 129-148. 
 
Senjo, S. & Leip, L.A. (2001). Testing and developing theory in drug court: A four part logit model to 
 predict drug court treatment.  Criminal Justice Policy Review, 12 (1), 66-87. 
 
Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science & 
 Medicine, 32(6), 705-714. 
 
Spohn, C., & Holleran, D. (2002). The effect of imprisonment on recidivism rates of felony offenders: a 
 focus on drug offenders*. Criminology, 40(2), 329-358. 
 
Spohn, C., Piper, R. K., Martin, T., & Frenzel, E. D. (2001). Drug courts and recidivism: The results of an 
 evaluation using two comparison groups and multiple indicators of recidivism. Journal of drug 
 issues,31(1), 149-176. 
95 
 
 
Spitzer, J. J. (1982). A primer on Box-Cox estimation. The Review of Economics and Statistics, 64(2), 
 307-313. 
 
Spjeldnes, S., Jung, H., Maguire, L., & Yamatani, H. (2012). Positive family social support: Counteracting 
 negative effects of mental illness and substance abuse to reduce jail ex-inmate recidivism 
 rates. Journal of Human Behavior in the Social Environment, 22(2), 130-147. 
 
Steadman, H. J., & Naples, M. (2005). Assessing the effectiveness of jail diversion programs for persons 
 with serious mental illness and co‐occurring substance use disorders. Behavioral Sciences & the 
 Law, 23(2), 163-170. 
 
Steadman, H., Osher, F., Robbins, P. C., Case, B., & Samuels, S. (2009). Prevalence of serious mental 
 illness among jail inmates. Psychiatric Services, 60 (6), 761-765. 
 
Steffensmeier, D., & Allan, E. (1996). Gender and crime: Toward a gendered theory of female 
 offending. Annual Review of Sociology, 22, 459-487. 
 
Stewart, S. H., Pihl, R. O., Conrod, P. J., & Dongier, M. (1998). Functional associations among trauma, 
 PTSD, and substance-related disorders. Addictive Behaviors, 23(6), 797-812. 
 
Stinchcomb, J. B. (2010). Drug courts: Conceptual foundation, empirical findings, and policy 
 implications. Drugs: Education, Prevention, and Policy, 17(2), 148-167. 
 
Stover, C. S., Hall, C., McMahon, T. J., & Easton, C. J. (2012). Fathers entering substance abuse 
 treatment: An examination of substance abuse, trauma symptoms and parenting 
 behaviors. Journal of Substance Abuse Treatment, 43(3), 335-343. 
 
Subica, A. M., Claypoole, K. H., & Wylie, A. M. (2012). PTSD'S mediation of the relationships between 
 trauma, depression, substance abuse, mental health, and physical health in individuals with 
 severe mental illness: Evaluating a comprehensive model. Schizophrenia Research, 136(1), 104-
 109. 
 
Substance Abuse and Mental Health Services Administration, Results from the 2011 National Survey on 
 Drug Use and Health: Summary of national findings, NSDUH Series H-44, HHS Publication No. 
 (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration, 
 2012. 
 
Sullivan, M. D., Edlund, M. J., Steffick, D., & Unützer, J. (2005). Regular use of prescribed opioids: 
 association with common psychiatric disorders. Pain, 119(1), 95-103. 
 
Taxman, F. S., & Bouffard, J. A. (2000). The importance of systems in improving offender outcomes: New 
 frontiers in treatment integrity. Justice Research and Policy, 2(2), 37-58. 
 
Thornberry, T. P., Lizotte, A. J., Krohn, M. D., Farnworth, M., & Jang, S. J. (1994). Delinquent Peers, 
Beliefs, And Delinquent Behavior: A Longitudinal Test Of Interactional Theory*.Criminology, 
32(1), 47-83. 
96 
 
 
Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, H. I. (2001). The Key Extended Entry Program (KEEP): 
 A methadone treatment program for opiate-dependent inmates. The Mount Sinai Journal of 
 Medicine, New York, 68(1), 14. 
 
Tonry, M. H., & Wilson, J. Q. (Eds.). (1990). Drugs and Crime (Vol. 13). Chicago: University of Chicago 
Press. 
 
Trebach, A. S., & Inciardi, J. A. (1993). Legalize it?: Debating American drug policy.  Washington, DC: 
American University Press. 
 
Triffleman, E. (2003). Issues in implementing posttraumatic stress disorder treatment outcome research 
in community-based treatment programs. In James L. Sorensen, Richard A. Rawson, Joseph 
Guydish, and Joan E. Zweben (Eds.), Drug abuse treatment through collaboration: Practice and 
research partnerships that work, 227-247. Washington, DC: American Psychological Association. 
 
Triffleman, E. G., Marmar, C. R., Delucchi, K. L., & Ronfeldt, H. (1995). Childhood trauma and 
 posttraumatic stress disorder in substance abuse inpatients. The Journal of Nervous and Mental 
 Disease, 183(3), 172-176. 
 
Turner, S., Longshore, D., Wenzel, S., Deschenes, E., Greenwood, P., Fain, T., ... & McBride, D. (2002). A 
 decade of drug treatment court research. Substance Use & Misuse, 37(12-13), 1489-1527. 
 
United States Department of Justice, Federal Bureau of Investigation. (September 2012). Crime in the 
 United States, 2011.  Washington, DC: Author. 
United States Department of Justice, Federal Bureau of Investigation. (September 2013). Crime in the 
 United States, 2012.  Washington, DC: Author. 
 
Velilla, S. 1993. A note on the multivariate Box–Cox transformation to normality. Statistics and 
 Probability Letters, 17, 259–263. 
 
Vreven, D. L., Gudanowski, D. M., King, L. A., & King, D. W. (1995). The civilian version of the Mississippi 
 PTSD Scale: A psychometric evaluation. Journal of Traumatic Stress, 8(1), 91-109. 
 
Walker, S. (2010).Sense & Nonsense about Crime.  Stamford, CT: Cengage Learning. 
 
Warner, T. D., & Kramer, J. H. (2009). Closing the revolving door? Substance abuse treatment as an 
 alternative to traditional sentencing for drug-dependent offenders. Criminal Justice and 
 Behavior, 36(1), 89-109. 
 
Warr, M. (2002). Companions in crime: The social aspects of criminal conduct.   Cambridge: Cambridge 
University Press. 
 
Warren, J. I., Stein, J. A., & Grella, C. E. (2007). Role of social support and self-efficacy in treatment 
 outcomes among clients with co-occurring disorders. Drug and Alcohol Dependence, 89(2), 267-
 274. 
 
97 
 
Webster, J. M., Rosen, P. J., Krietemeyer, J., Mateyoke-Scrivner, A., Staton-Tindall, M., & Leukefeld, C. 
 (2006). Gender, mental health, and treatment motivation in a drug court setting. Journal of 
 Psychoactive Drugs,38(4), 441-448. 
 
Wexler, H.K. 1994. Progress in prison substance abuse treatment: A 5 year report. Journal of Drug Issues, 
 24(2): 361-372. 
 
Wexler, D. B. (2001). Lowering the volume through legal doctrine: A promising path for therapeutic 
 jurisprudence scholarship. Florida Coastal Law Journal, 3, 123. 
 
Weyandt, L. L., Janusis, G., Wilson, K. G., Verdi, G., Paquin, G., Lopes, J., ... & Dussault, C. (2009). 
 Nonmedical prescription stimulant use among a sample of college students relationship with 
 psychological variables. Journal of Attention Disorders, 13(3), 284-296. 
 
White, H. R., & Gorman, D. M. (2000). Dynamics of the drug-crime relationship. Criminal Justice, 1(15), 1-
 218. 
 
Wilson, D. B., Mitchell, O., & MacKenzie, D. L. (2006). A systematic review of drug court effects on 
 recidivism. Journal of Experimental Criminology, 2(4), 459-487. 
 
Wilson, J. Q., & Petersilia, J. (Eds.). (2010). Crime and public policy. Oxford University Press. 
 
Wu, N. S., Schairer, L. C., Dellor, E., & Grella, C. (2010). Childhood trauma and health outcomes in adults 
 with comorbid substance abuse and mental health disorders. Addictive Behaviors, 35(1), 68-71. 
 
Young, D., & Belenko, S. (2002). Program retention and perceived coercion in three models of 
 mandatory drug treatment. Journal of Drug Issues, 32(1), 297-328. 
 
Zanis, D. A., Mulvaney, F., Coviello, D., Alterman, A. I., Savitz, B., & Thompson, W. (2003). The 
 effectiveness of early parole to substance abuse treatment facilities on 24-month criminal 
 recidivism. Journal of Drug Issues, 33(1), 223-235. 
 
Zweig, J. M., Rossman, S. B., Roman, J. K., Rempel, M., Lindquist, C. H., Roman, J.K., et al. (2011). The 
 Multi-Site Adult Drug Court: What’s Happening with Drug Courts? A Portrait of Adult Drug Courts 
 in 2004. Washington, DC: The Urban Institute. 
  
98 
 
 
 
 
 
 
Appendix A: Extant Literature on Drug Court Outcomes 
 
Demographics Extant Literature 
Gender No gender differences: 
 Evans, Li, & Hyser, 2009 
 Hepburn & Harvey, 2007 
 Marlowe, et. al, 2003 
 Seachrest, & Shicor, 2001 
 Senjo & Leip, ,2001 
Males more likely to complete drug court: 
 Belenko, 2001 
Females more likely to complete drug court: 
 Gray & Saum, 2005 
 Dannerbeck, Harris, Sundet, & Lloyd, 2006 
 Hartman, Johnson Listwan, & Koetzle Shaffer, 2007 
Employment Those employed more likely to complete: 
 Butzin, Saum, & Scarpetti, 2002 
 Zweig, et al., 2011 
Age No age differences: 
 DeMatteo, Marlowe, Festinger, & Arabia, 2009 
 Gray & Saum, 2005 
 Gallagher, 2013 
 Miller & Shutt, 2001 
 Roll, Pendergast, Richardson, Burdon, & Ramirez, 2005 
 Shaffer et al., 2010 
 Schiff &Terry, 1997 
Older adults more likely to complete: 
 Cissner & Rempel, 2005 
 Hartley & Phillips, 2001 
 Hickert, Boyle & Tollefson, 2009 
 Hepburn & Harvey, 2007 
 Young and Belenko, 2002 
Younger adults more likely to complete: 
 Senjo & Leip. 2001 
Younger adults less likely to complete: 
 Dannerbeck, Harris, Sundet, & Lloyd, 2006 
 Hickert, Boyle, & Tollefsen,2009 
 Logan, Williams, Leukefeld, & Minton, 2000 
 Saum, Scarpitti, & Robbins, 2001 
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Demographics Extant Literature 
Education level No education differences: 
 Senjo & Leip, 2001 
 Hiller, Knight, & Simpson, 1999 
 DeMatteo et al., 2009 
 Gray & Saum, 2005 
 Hepburn & Harvey, 2007;  
 Hickert, Boyle, & Tollefson, 2009;  
 Schaeffer et al., 2010;  
 Mullany & Peat, 2008;  
 Schiff & Terry, 1997 
Psychosocial Characteristics Extant Literature 
Trauma No studies specifically examine traumatic experiences in terms of 
drug court outcomes, but  the literature on treatment completion 
indicates a negative relationship between traumatic stress 
experiences and successful completion of treatment. 
MH  No mental health differences: 
 Dematteo, Marlowe, Festinger, & Arabia, 2009 
 Cosden, et al, 2006 
More mental health symptoms less likely to complete: 
 Cissner& Rempel , 2005 
 Evans, Li, & Hser, 2009 
 Garrity, et al, 2007 
 Gray & Saum, 2005 
 Hickert, Boyle, & Tollefson, 2007 
 Hickert, et al, 2009 
 Hiller, Knight, & Simpson, 1999 
 Mendoza, Trinidad, Nochajaski, & Farrell, 2013 
Social support No studies specifically examine social support in terms of drug 
court outcomes, but a large amount of literature on treatment 
completion indicates a positive relationship between prosocial 
support mechanisms and successful completion of treatment. 
 
 
 
